"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0",0,"0",0,0,0,"0","0"
"NM_170707.4(LMNA):c.664C>T (p.His222Tyr)","LMNA","H222Y, H141Y, H110Y","Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided","Pathogenic(Last reviewed: Jan 17, 2013)","no assertion criteria provided","VCV000014492","1",156104620,"1",156134829,14492,29531,"rs28928901","NC_000001.11:156134828:C:T"
"NM_170707.4(LMNA):c.254T>G (p.Leu85Arg)","LMNA","L85R","not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Dec 2, 1999)","no assertion criteria provided","VCV000014480","1",156084963,"1",156115172,14480,29519,"rs28933090","NC_000001.11:156115171:T:G"
"NM_170707.4(LMNA):c.169G>C (p.Ala57Pro)","LMNA","A57P","not provided|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome","Pathogenic(Last reviewed: Feb 15, 2009)","no assertion criteria provided","VCV000014506","1",156084878,"1",156115087,14506,29545,"rs28928903","NC_000001.11:156115086:G:C"
"NM_000702.4(ATP1A2):c.1133C>A (p.Thr378Asn)","ATP1A2","T378N","Alternating hemiplegia of childhood 1|Familial hemiplegic migraine","Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2019)","criteria provided, conflicting interpretations","VCV000012921","1",160098557,"1",160128767,12921,27960,"rs28934002","NC_000001.11:160128766:C:A"
"NM_000702.4(ATP1A2):c.2291T>C (p.Leu764Pro)","ATP1A2","L764P","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012917","1",160105635,"1",160135845,12917,27956,"rs28933398","NC_000001.11:160135844:T:C"
"NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)","ATP1A2","W887R","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012918","1",160106455,"1",160136665,12918,27957,"rs28933399","NC_000001.11:160136664:T:C"
"NM_000488.3(SERPINC1):c.166C>T (p.Arg56Cys)","SERPINC1","R56C, R8C","Antithrombin III deficiency|not provided","Likely pathogenic(Last reviewed: Oct 7, 2016)","criteria provided, single submitter","VCV000018022","1",173883933,"1",173914795,18022,33061,"rs28929469","NC_000001.11:173914794:G:A"
"NM_000157.4(GBA):c.680A>G (p.Asn227Ser)","GBA|LOC106627981","N227S, N140S, N178S","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004314","1",155208006,"1",155238215,4314,19353,"rs364897","NC_000001.11:155238214:T:C"
"NM_000157.3(GBA):c.1448T>C","GBA|LOC106627981","L483P, L396P, L434P","not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease|Dementia, Lewy body, susceptibility to|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Thoracolumbar scoliosis|Resting tremor|Parkinsonism|Hypomimic face|Movement disorder","Pathogenic, risk factor(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004288","1",155205043,"1",155235252,4288,19327,"rs421016","NC_000001.11:155235251:A:G"
"NM_000157.4(GBA):c.1342G>C (p.Asp448His)","GBA|LOC106627981","D448H, D361H, D399H","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|Gaucher disease type II|Lewy body dementia|not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004293","1",155205518,"1",155235727,4293,19332,"rs1064651","NC_000001.11:155235726:C:G"
"NM_024009.3(GJB3):c.101T>C (p.Leu34Pro)","GJB3","L34P","Erythrokeratodermia variabilis et progressiva 1","Pathogenic(Last reviewed: May 15, 2002)","no assertion criteria provided","VCV000006491","1",35250464,"1",34784863,6491,21530,"rs28937583","NC_000001.11:34784862:T:C"
"NM_005957.5(MTHFR):c.665C>T (p.Ala222Val)","MTHFR","A222V, A263V","not provided|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|cyclophosphamide response - Toxicity/ADR|carboplatin response - Efficacy|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|methotrexate response - Dosage, Efficacy, Toxicity/ADR|Thrombophilia due to thrombin defect|none provided|Homocystinuria due to MTHFR deficiency|MTHFR deficiency, thermolabile type|not specified|Neoplasm of stomach","drug response(Last reviewed: May 14, 2018)","reviewed by expert panel","VCV000003520","1",11856378,"1",11796321,3520,18559,"rs1801133","NC_000001.11:11796320:G:A"
"NM_001122764.3(PPOX):c.1046A>C (p.Asp349Ala)","PPOX","D349A, D187A, D213A, D316A","Variegate porphyria, homozygous","Pathogenic(Last reviewed: Nov 1, 1998)","no assertion criteria provided","VCV000008698","1",161140257,"1",161170467,8698,23737,"rs28936676","NC_000001.11:161170466:A:C"
"NM_001122764.3(PPOX):c.35T>C (p.Ile12Thr)","PPOX","I12T","Variegate porphyria, homozygous","Pathogenic(Last reviewed: Apr 1, 2001)","no assertion criteria provided","VCV000008703","1",161136672,"1",161166882,8703,23742,"rs28936677","NC_000001.11:161166881:T:C"
"NM_000350.2(ABCA4):c.5882G>A","ABCA4","G1961E","Retinal dystrophy|Cone-rod dystrophy 3|Stargardt disease 1|Retinitis pigmentosa 19|not provided|Stargardt disease|Retinitis pigmentosa 19|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Cone-rod dystrophy 3|none provided|Stargardt disease 1|ABCA4-Related Disorders|Joubert syndrome 5|Inborn genetic diseases|Macular dystrophy|Age-related macular degeneration 2","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000007888","1",94473807,"1",94008251,7888,22927,"rs1800553","NC_000001.11:94008250:C:T"
"NM_000447.3(PSEN2):c.715A>G (p.Met239Val)","PSEN2","M239V","not provided|Alzheimer disease, type 4","Pathogenic(Last reviewed: Aug 31, 1995)","no assertion criteria provided","VCV000008846","1",227076678,"1",226888977,8846,23885,"rs28936379","NC_000001.11:226888976:A:G"
"NM_174936.3(PCSK9):c.158C>G (p.Ala53Gly)","PCSK9","A53G","Familial hypercholesterolemia|Familial hypercholesterolemia 1|Familial hypercholesterolemia 3|not specified|Hypobetalipoproteinemia","Uncertain significance(Last reviewed: Jul 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000440708","1",55505668,"1",55039995,440708,434137,"rs11583680","NC_000001.11:55039994:C:G"
"NM_000143.3(FH):c.1021G>A (p.Asp341Asn)","FH","D341N","Fumarase deficiency","Likely pathogenic(Last reviewed: Jul 13, 2017)","criteria provided, single submitter","VCV000405923","1",241667429,"1",241504129,405923,391128,"rs11545655","NC_000001.11:241504128:C:T"
"NM_000702.4(ATP1A2):c.1133C>T (p.Thr378Ile)","ATP1A2","T378I","Familial hemiplegic migraine|not specified","Uncertain significance(Last reviewed: Nov 27, 2017)","criteria provided, multiple submitters, no conflicts","VCV000392148","1",160098557,"1",160128767,392148,364492,"rs28934002","NC_000001.11:160128766:C:T"
"NM_001244753.2(FCGR3B):c.316A>G (p.Ile106Val)","FCGR3B","I106V, I105V, I89V","not specified","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000402858","1",161599571,"1",161629781,402858,389362,"rs2290834","NC_000001.11:161629780:T:C"
"NM_000350.3(ABCA4):c.5603A>T (p.Asn1868Ile)","ABCA4","N1868I","Age-related macular degeneration 2|Stargardt disease 1|Macular degeneration|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|ABCA4-Related Disorders|Cone-rod dystrophy 3|Stargardt disease|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2021)","criteria provided, conflicting interpretations","VCV000099390","1",94476467,"1",94010911,99390,105279,"rs1801466","NC_000001.11:94010910:T:A"
"NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)","GBA|LOC106627981","L483R, L434R, L396R","not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease","Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093449","1",155205043,"1",155235252,93449,99356,"rs421016","NC_000001.11:155235251:A:C"
"NM_000157.4(GBA):c.1497G>C (p.Val499=)","GBA|LOC106627981","","not specified","Benign/Likely benign(Last reviewed: Jul 21, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093451","1",155204994,"1",155235203,93451,38385,"rs1135675","NC_000001.11:155235202:C:G"
"NM_000157.4(GBA):c.681T>G (p.Asn227Lys)","GBA|LOC106627981","N227K, N140K, N178K","Gaucher disease type II|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type III|not provided|Gaucher disease","Pathogenic(Last reviewed: May 26, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093458","1",155208005,"1",155238214,93458,99363,"rs381418","NC_000001.11:155238213:A:C"
"NM_170707.4(LMNA):c.254T>A (p.Leu85His)","LMNA","L85H","Charcot-Marie-Tooth disease, type 2","Uncertain significance(Last reviewed: Dec 16, 2015)","criteria provided, single submitter","VCV000242004","1",156084963,"1",156115172,242004,238146,"rs28933090","NC_000001.11:156115171:T:A"
"NM_000570.4(FCGR3B):c.316A= (p.Ile106=)","FCGR3B","","","no interpretation for the single variant","no interpretation for the single variant","VCV000242687","1",161599571,"1",161629781,242687,45585,"rs2290834","NC_000001.11:161629780:T:T"
"NM_001083116.3(PRF1):c.1034C>T (p.Pro345Leu)","PRF1","P345L","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Dec 3, 1999)","no assertion criteria provided","VCV000013713","10",72358443,"10",70598687,13713,28752,"rs28933374","NC_000010.11:70598686:G:A"
"NM_001354.5(AKR1C2):c.666T>G (p.His222Gln)","AKR1C2","H222Q, H196Q","46,XY sex reversal 8","Pathogenic(Last reviewed: Aug 12, 2011)","no assertion criteria provided","VCV000030067","10",5037962,"10",4995770,30067,39022,"rs13222","NC_000010.11:4995769:A:C"
"NM_001008212.2(OPTN):c.293T>A (p.Met98Lys)","OPTN|LOC108903148","M98K","Primary open angle glaucoma|Glaucoma, normal tension, susceptibility to|not specified|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|none provided|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007099","10",13152400,"10",13110400,7099,22138,"rs11258194","NC_000010.11:13110399:T:A"
"NM_001354.5(AKR1C2):c.666T>C (p.His222=)","AKR1C2","","CIC-DUX Sarcoma","Pathogenic","no assertion criteria provided","VCV000805966","10",5037962,"10",4995770,805966,794307,"rs13222","NC_000010.11:4995769:A:G"
"CYP2C19*4A/*26","CYP2C19","D256N","Voriconazole response|Citalopram response|Escitalopram response|Sertraline response","drug response","practice guideline","VCV000633985","10",96541701,"10",94781944,633985,166409,"rs375781227","NC_000010.11:94781943:G:A"
"CYP2C19*4A/*33","CYP2C19","D188N","Escitalopram response|Voriconazole response|Sertraline response|Citalopram response","drug response","practice guideline","VCV000634163","10",96540336,"10",94780579,634163,622290,"rs370803989","NC_000010.11:94780578:G:A"
"NM_000124.4(ERCC6):c.3637A>G (p.Arg1213Gly)","ERCC6","R1213G","not provided|Macular degeneration|Cockayne syndrome|COFS syndrome|not specified","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000129017","10",50678369,"10",49470323,129017,134463,"rs2228527","NC_000010.11:49470322:T:C"
"NM_000360.4(TH):c.733A>C (p.Thr245Pro)","TH","T276P, T245P, T272P","Autosomal recessive DOPA responsive dystonia","Pathogenic(Last reviewed: Jan 1, 2000)","no assertion criteria provided","VCV000012329","11",2188225,"11",2166995,12329,27368,"rs28934581","NC_000011.10:2166994:T:G"
"NM_001567.4(INPPL1):c.2415+1G>A","INPPL1","","Opsismodysplasia","Pathogenic(Last reviewed: Jan 10, 2013)","no assertion criteria provided","VCV000039476","11",71945660,"11",72234616,39476,48075,"rs655423","NC_000011.10:72234615:G:A"
"NM_000352.6(ABCC8):c.4055G>C (p.Arg1352Pro)","ABCC8","R1353P, R1352P, R1374P, R1351P","Hyperinsulinemic hypoglycemia, familial, 1","Pathogenic(Last reviewed: Oct 1, 1998)","no assertion criteria provided","VCV000009094","11",17418527,"11",17396980,9094,24133,"rs28936370","NC_000011.10:17396979:C:G"
"NM_000352.6(ABCC8):c.4055G>A (p.Arg1352His)","ABCC8","R1353H, R1352H, R1374H, R1351H","Leucine-induced hypoglycemia","Pathogenic(Last reviewed: Sep 1, 2004)","no assertion criteria provided","VCV000009098","11",17418527,"11",17396980,9098,24137,"rs28936370","NC_000011.10:17396979:C:T"
"NM_000051.3(ATM):c.6108T>A (p.Tyr2036Ter)","ATM|C11orf65","Y2036*","Ataxia telangiectasi","Pathogenic(Last reviewed: May 15, 2019)","criteria provided, single submitter","VCV000635341","11",108186750,"11",108316023,635341,623153,"rs3092826","NC_000011.10:108316022:T:A"
"NM_000051.3(ATM):c.6108T>G (p.Tyr2036Ter)","ATM|C11orf65","Y2036*","Ataxia-telangiectasia syndrome","Pathogenic(Last reviewed: Jul 11, 2018)","criteria provided, single submitter","VCV000664270","11",108186750,"11",108316023,664270,639571,"rs3092826","NC_000011.10:108316022:T:G"
"NM_000256.3(MYBPC3):c.1147C>G (p.Leu383Val)","MYBPC3","L383V","Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2019)","criteria provided, conflicting interpretations","VCV000181062","11",47365119,"11",47343568,181062,179338,"rs11570077","NC_000011.10:47343567:G:C"
"NM_000051.3(ATM):c.6108T>C (p.Tyr2036=)","ATM|C11orf65","","not provided|Malignant tumor of breast|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000185724","11",108186750,"11",108316023,185724,183342,"rs3092826","NC_000011.10:108316022:T:C"
"NM_000217.3(KCNA1):c.731C>A (p.Pro244His)","KCNA1","P244H","Myokymia 1","Pathogenic(Last reviewed: Oct 1, 2000)","no assertion criteria provided","VCV000013490","12",5021275,"12",4912109,13490,28529,"rs28933382","NC_000012.12:4912108:C:A"
"NM_000217.3(KCNA1):c.677C>G (p.Thr226Arg)","KCNA1","T226R","Episodic ataxia type 1","Pathogenic(Last reviewed: Aug 16, 2012)","no assertion criteria provided","VCV000013492","12",5021221,"12",4912055,13492,28531,"rs28933383","NC_000012.12:4912054:C:G"
"NM_000217.3(KCNA1):c.677C>A (p.Thr226Lys)","KCNA1","T226K","Myokymia 1","Pathogenic(Last reviewed: Apr 1, 2007)","no assertion criteria provided","VCV000013493","12",5021221,"12",4912055,13493,28532,"rs28933383","NC_000012.12:4912054:C:A"
"NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro)","TNFRSF1A","R92P, R121P, R13P","TNF receptor-associated periodic fever syndrome (TRAPS)","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000012341","12",6442643,"12",6333477,12341,27380,"rs4149584","NC_000012.12:6333476:C:G"
"NM_000431.4(MVK):c.1129G>A (p.Val377Ile)","MVK","V377I, V325I","Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|not specified|not provided|Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever|MVK-Related Disorders","Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2021)","criteria provided, conflicting interpretations","VCV000011929","12",110034320,"12",109596515,11929,26968,"rs28934897","NC_000012.12:109596514:G:A"
"NM_000217.3(KCNA1):c.677C>T (p.Thr226Met)","KCNA1","T226M","Episodic ataxia type 1","Pathogenic(Last reviewed: Aug 16, 2012)","no assertion criteria provided","VCV000021127","12",5021221,"12",4912055,21127,33979,"rs28933383","NC_000012.12:4912054:C:T"
"NM_170665.4(ATP2A2):c.68G>A (p.Gly23Glu)","ATP2A2","G23E","Keratosis follicularis|not provided","Pathogenic(Last reviewed: Aug 19, 2015)","criteria provided, single submitter","VCV000017789","12",110719662,"12",110281857,17789,32828,"rs28929478","NC_000012.12:110281856:G:A"
"NM_020638.3(FGF23):c.535C>T (p.Arg179Trp)","FGF23","R179W","not provided|Autosomal dominant hypophosphatemic rickets","Likely pathogenic(Last reviewed: Nov 20, 2015)","criteria provided, single submitter","VCV000005026","12",4479730,"12",4370564,5026,20065,"rs28937882","NC_000012.12:4370563:G:A"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12",121175678,"12",120737875,3830,18869,"rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.1241A>G (p.Tyr414Cys)","PAH","Y414C","Phenylketonuria|not provided|Hyperphenylalaninemia, non-pku","Pathogenic(Last reviewed: Jul 27, 2018)","reviewed by expert panel","VCV000000593","12",103234252,"12",102840474,593,15632,"rs5030860","NC_000012.12:102840473:T:C"
"NM_000552.5(VWF):c.4196G>A","VWF","R1399H","Abnormality of coagulation|not provided|VON WILLEBRAND FACTOR POLYMORPHISM|von Willebrand disease type 1|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2019)","criteria provided, conflicting interpretations","VCV000000293","12",6128388,"12",6019222,293,15332,"rs1800382","NC_000012.12:6019221:C:T"
"NM_002150.3(HPD):c.97= (p.Thr33=)","HPD","","Tyrosinemia type 3|Hawkinsinuria|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000001577","12",122295335,"12",121857429,1577,16616,"rs1154510","NC_000012.12:121857428:T:T"
"NM_000785.4(CYP27B1):c.1004G>C (p.Arg335Pro)","CYP27B1","R335P","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001660","12",58158293,"12",57764510,1660,16699,"rs28934606","NC_000012.12:57764509:C:G"
"NM_000020.2(ACVRL1):c.1127T>G (p.Met376Arg)","ACVRL1","M376R","Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Jun 1, 1996)","no assertion criteria provided","VCV000008244","12",52309898,"12",51916114,8244,23283,"rs28936399","NC_000012.12:51916113:T:G"
"NM_000618.5(IGF1):c.285C>A (p.Cys95Ter)","IGF1","C95*, C79*","Growth delay due to insulin-like growth factor type 1 deficiency","Likely pathogenic(Last reviewed: Apr 16, 2019)","no assertion criteria provided","VCV000829837","12",102813404,"12",102419626,829837,818294,"rs3730193","NC_000012.12:102419625:G:T"
"NM_000618.5(IGF1):c.285C>T (p.Cys95=)","IGF1","","not provided|Growth delay due to insulin-like growth factor type 1 deficiency","Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000731380","12",102813404,"12",102419626,731380,738394,"rs3730193","NC_000012.12:102419625:G:A"
"NM_002150.3(HPD):c.97A>G (p.Thr33Ala)","HPD","T33A","Hawkinsinuria|Tyrosinemia type 3|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000802899","12",122295335,"12",121857429,802899,791201,"rs1154510","NC_000012.12:121857428:T:C"
"NM_000552.4(VWF):c.1548T>A (p.Tyr516Ter)","VWF","Y516*","not provided","Pathogenic(Last reviewed: Mar 16, 2018)","criteria provided, single submitter","VCV000619930","12",6167196,"12",6058030,619930,611150,"rs1800379","NC_000012.12:6058029:A:T"
"NM_000552.4(VWF):c.1548T>C (p.Tyr516=)","VWF","","not provided|not specified|none provided|von Willebrand disorder","Benign/Likely benign(Last reviewed: Aug 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256655","12",6167196,"12",6058030,256655,254693,"rs1800379","NC_000012.12:6058029:A:G"
"NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln)","TNFRSF1A","R121Q, R13Q","TNF receptor-associated periodic fever syndrome (TRAPS)|Multiple sclerosis, susceptibility to, 5|not specified|none provided|TNF receptor-associated periodic fever syndrome (TRAPS)|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000217017","12",6442643,"12",6333477,217017,213624,"rs4149584","NC_000012.12:6333476:C:T"
"NM_000059.4(BRCA2):c.5640T>G (p.Asn1880Lys)","BRCA2","N1880K","Breast neoplasm|Hereditary cancer-predisposing syndrome|not specified|none provided|Breast and/or ovarian cancer|Fanconi anemia, complementation group D1|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome","Benign(Last reviewed: Jun 18, 2019)","reviewed by expert panel","VCV000051896","13",32914132,"13",32339995,51896,66564,"rs11571657","NC_000013.11:32339994:T:G"
"NM_001846.4(COL4A2):c.4987G>A (p.Gly1663Ser)","COL4A2","G1663S","Optic nerve hypoplasia|not provided|Porencephaly 2","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000311195","13",111164386,"13",110512039,311195,327447,"rs12877501","NC_000013.11:110512038:G:A"
"NM_000257.4(MYH7):c.5533C>T (p.Arg1845Trp)","MYH7","R1845W","not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myosin storage myopathy","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000014114","14",23884230,"14",23415021,14114,29153,"rs28933098","NC_000014.9:23415020:G:A"
"NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)","NFKBIA","S32I","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Sep 6, 2004)","no assertion criteria provided","VCV000014003","14",35873756,"14",35404550,14003,29042,"rs28933100","NC_000014.9:35404549:C:A"
"NM_006194.3(PAX9):c.62T>C (p.Leu21Pro)","PAX9","L21P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013771","14",37132159,"14",36662954,13771,28810,"rs28933970","NC_000014.9:36662953:T:C"
"NM_006194.3(PAX9):c.83G>C (p.Arg28Pro)","PAX9","R28P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000013773","14",37132180,"14",36662975,13773,28812,"rs28933971","NC_000014.9:36662974:G:C"
"NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)","PAX9","R26W","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013774","14",37132173,"14",36662968,13774,28813,"rs28933972","NC_000014.9:36662967:C:T"
"NM_001040108.1(MLH3):c.2221G>T (p.Val741Phe)","AREL1|MLH3","V741F","Endometrial carcinoma|not provided|Hereditary nonpolyposis colorectal cancer type 7","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005561","14",75514138,"14",75047435,5561,20600,"rs28756990","NC_000014.9:75047434:C:A"
"NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)","NFKBIA","S32N","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Nov 15, 2018)","no assertion criteria provided","VCV000590311","14",35873756,"14",35404550,590311,581252,"rs28933100","NC_000014.9:35404549:C:T"
"NM_000153.4(GALC):c.169G>A (p.Gly57Ser)","GALC","G57S","not provided|Galactosylceramide beta-galactosidase deficiency","Pathogenic(Last reviewed: Jun 6, 2017)","criteria provided, multiple submitters, no conflicts","VCV000193054","14",88459340,"14",87992996,193054,190219,"rs11623","NC_000014.9:87992995:C:T"
"NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)","NR2E3","R311Q","Retinal dystrophy|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 37|Goldmann-Favre syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000005532","15",72105913,"15",71813573,5532,20571,"rs28937873","NC_000015.10:71813572:G:A"
"NM_000138.4(FBN1):c.3458G>A (p.Cys1153Tyr)","FBN1","C1153Y","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic(Last reviewed: Jan 27, 2017)","criteria provided, single submitter","VCV000457194","15",48779514,"15",48487317,457194,465123,"rs140599","NC_000015.10:48487316:C:T"
"NM_014249.4(NR2E3):c.951del (p.Thr318fs)","NR2E3","T318fs","not provided|Autosomal recessive retinitis pigmentosa","Likely benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000445726","15",72105929,"15",71813589,445726,438998,"rs11351249","NC_000015.10:71813588:CCCC:CCC"
"NM_001021.6(RPS17):c.159T>C (p.Tyr53=)","RPS17","","not specified","Uncertain significance(Last reviewed: Feb 16, 2017)","criteria provided, single submitter","VCV000419839","15",82823390,"15",82538982,419839,409353,"rs6991","NC_000015.10:82538981:A:G"
"NM_001021.6(RPS17):c.159T>G (p.Tyr53Ter)","RPS17","Y53*","Diamond-Blackfan anemia 4","Pathogenic(Last reviewed: Aug 1, 2013)","no assertion criteria provided","VCV000100625","15",82823390,"15",82538982,100625,106497,"rs6991","NC_000015.10:82538981:A:C"
"NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)","MC1R","R160W","not specified|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014310","16",89986144,"16",89919736,14310,29349,"rs1805008","NC_000016.10:89919735:C:T"
"NM_002386.3(MC1R):c.451C>T (p.Arg151Cys)","MC1R","R151C","Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014312","16",89986117,"16",89919709,14312,29351,"rs1805007","NC_000016.10:89919708:C:T"
"NM_000418.4(IL4R):c.223A>G (p.Ile75Val)","IL4R","I75V, I60V","Atopy, resistance to|Acquired immunodeficiency syndrome, slow progression to","Pathogenic, protective(Last reviewed: Oct 1, 2005)","no assertion criteria provided","VCV000014666","16",27356203,"16",27344882,14666,29705,"rs1805010","NC_000016.10:27344881:A:G"
"NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)","UMOD","C217R, C250R","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 17, 2004)","no assertion criteria provided","VCV000012256","16",20359974,"16",20348652,12256,27295,"rs28934583","NC_000016.10:20348651:A:G"
"NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)","UMOD","G103C, G136C","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 1, 2002)","no assertion criteria provided","VCV000012257","16",20360316,"16",20348994,12257,27296,"rs28934584","NC_000016.10:20348993:C:A"
"NM_000558.5(HBA1):c.223G>A (p.Asp75Asn)","HBA1|LOC106804613","D75N","HEMOGLOBIN G (PEST)","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015732","16",227055,"16",177056,15732,30771,"rs28928875","NC_000016.10:177055:G:A"
"NM_003361.3(UMOD):c.649T>G (p.Cys217Gly)","UMOD","C217G, C250G","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Jan 6, 2012)","no assertion criteria provided","VCV000039418","16",20359974,"16",20348652,39418,48017,"rs28934583","NC_000016.10:20348651:A:C"
"NM_000558.5(HBA1):c.223G>C (p.Asp75His)","HBA1|LOC106804613","D75H","none provided|not provided|HEMOGLOBIN Q (THAILAND)|HEMOGLOBIN MAHIDOL|HEMOGLOBIN ASABARA|HEMOGLOBIN KURASHIKI|HEMOGLOBIN G (TAICHUNG)|HEMOGLOBIN Q|alpha Thalassemia","Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2019)","criteria provided, conflicting interpretations","VCV000015733","16",227055,"16",177056,15733,30772,"rs28928875","NC_000016.10:177055:G:C"
"NM_000558.3(HBA1):c.179G>T (p.Gly60Val)","HBA1|LOC106804613","G60V","HEMOGLOBIN TOTTORI","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015827","16",227011,"16",177012,15827,30866,"rs28928878","NC_000016.10:177011:G:T"
"NM_000558.3(HBA1):c.179G>A (p.Gly60Asp)","HBA1|LOC106804613","G60D","Hemoglobin H disease, nondeletional|HEMOGLOBIN ADANA|not provided","Pathogenic(Last reviewed: Mar 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015849","16",227011,"16",177012,15849,30888,"rs28928878","NC_000016.10:177011:G:A"
"NM_021615.5(CHST6):c.609C>A (p.Asp203Glu)","CHST6","D203E","Macular corneal dystrophy","Pathogenic(Last reviewed: Oct 1, 2000)","no assertion criteria provided","VCV000005072","16",75513118,"16",75479220,5072,20111,"rs28937878","NC_000016.10:75479219:G:T"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16",75513128,"16",75479230,5075,20114,"rs28937879","NC_000016.10:75479229:A:C"
"NM_001040667.3(HSF4):c.355C>T (p.Arg119Cys)","HSF4","R119C","Cataract 5 multiple types","Pathogenic(Last reviewed: Jul 1, 2002)","no assertion criteria provided","VCV000007093","16",67199744,"16",67165841,7093,22132,"rs28937573","NC_000016.10:67165840:C:T"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16",3304626,"16",3254626,2542,17581,"rs3743930","NC_000016.10:3254625:C:G"
"NM_001126108.2(SLC12A3):c.1196G>T (p.Arg399Leu)","SLC12A3","R399L, R398L","not provided|Familial hypokalemia-hypomagnesemia","Likely pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000381528","16",56913000,"16",56879088,381528,375217,"rs13306668","NC_000016.10:56879087:G:T"
"NM_004608.3(TBX6):c.-48-240A>G","TBX6","","","no interpretation for the single variant","no interpretation for the single variant","VCV000427808","16",30102802,"16",30091481,427808,418555,"rs3809624","NC_000016.10:30091480:T:C"
"NM_002474.3(MYH11):c.4401C>T (p.Tyr1467=)","MYH11|NDE1","","not specified|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Lissencephaly, Recessive|Aortic aneurysm, familial thoracic 4|none provided","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000138343","16",15815456,"16",15721599,138343,142046,"rs8046180","NC_000016.10:15721598:G:A"
"NM_002474.3(MYH11):c.4401C>G (p.Tyr1467Ter)","MYH11|NDE1","Y1467*, Y1474*","Aortic aneurysm, familial thoracic 4","Pathogenic(Last reviewed: Nov 16, 2019)","criteria provided, single submitter","VCV000201075","16",15815456,"16",15721599,201075,197866,"rs8046180","NC_000016.10:15721598:G:C"
"NM_000422.3(KRT17):c.274A>G (p.Asn92Asp)","KRT17","N92D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Nov 3, 2016)","criteria provided, single submitter","VCV000014586","17",39780488,"17",41624236,14586,29625,"rs28928896","NC_000017.11:41624235:T:C"
"NM_000422.3(KRT17):c.274A>C (p.Asn92His)","KRT17","N92H","not provided|Steatocystoma multiplex","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014589","17",39780488,"17",41624236,14589,29628,"rs28928896","NC_000017.11:41624235:T:G"
"NM_000546.6(TP53):c.215C>G (p.Pro72Arg)","TP53","P72R, P33R","not specified|not provided|Li-Fraumeni syndrome|fluorouracil response - Efficacy, Toxicity/ADR|paclitaxel response - Efficacy, Toxicity/ADR|antineoplastic agents response - Efficacy, Toxicity/ADR|cisplatin response - Efficacy, Toxicity/ADR|cyclophosphamide response - Efficacy, Toxicity/ADR|Li-Fraumeni syndrome 1|CODON 72 POLYMORPHISM|none provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome","drug response(Last reviewed: Oct 17, 2016)","reviewed by expert panel","VCV000012351","17",7579472,"17",7676154,12351,27390,"rs1042522","NC_000017.11:7676153:G:C"
"NM_000546.6(TP53):c.844C>T (p.Arg282Trp)","TP53","R282W, R150W, R243W, R123W","Hereditary cancer-predisposing syndrome|Malignant melanoma of skin|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Non-Hodgkin lymphoma|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Pleomorphic xanthoastrocytoma|Astrocytoma, anaplastic|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Glioblastoma|Li-Fraumeni-like syndrome|Neoplasm of ovary|Adenocarcinoma of stomach|Colorectal cancer|Carcinoma of esophagus","Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012364","17",7577094,"17",7673776,12364,27403,"rs28934574","NC_000017.11:7673775:G:A"
"NM_000546.5(TP53):c.451C>A (p.Pro151Thr)","TP53","P151T, P112T, P19T","Uterine Carcinosarcoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Rhabdomyosarcoma (disease)|Multiple myeloma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Neoplasm of brain|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Malignant melanoma of skin|Hereditary cancer-predisposing syndrome|Breast neoplasm|Transitional cell carcinoma of the bladder|not provided|Lung adenocarcinoma","Likely pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012369","17",7578479,"17",7675161,12369,27408,"rs28934874","NC_000017.11:7675160:G:T"
"NM_000546.6(TP53):c.451C>T (p.Pro151Ser)","TP53","P151S, P112S, P19S","Breast neoplasm|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Multiple myeloma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Hepatocellular carcinoma|Neoplasm of ovary|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Uterine Carcinosarcoma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012370","17",7578479,"17",7675161,12370,27409,"rs28934874","NC_000017.11:7675160:G:A"
"NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)","BRCA1","R1347G, R1300G","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|not provided|not specified|Familial cancer of breast|none provided|Breast and/or ovarian cancer","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000041821","17",41243509,"17",43091492,41821,50260,"rs28897689","NC_000017.11:43091491:T:C"
"NM_000342.3(SLC4A1):c.2608C>T (p.Arg870Trp)","SLC4A1","R870W","Spherocytosis type 4|not provided","Likely pathogenic(Last reviewed: Jan 15, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017776","17",42328574,"17",44251206,17776,32815,"rs28931585","NC_000017.11:44251205:G:A"
"NM_000342.3(SLC4A1):c.1462G>A (p.Val488Met)","SLC4A1","V488M","Renal tubular acidosis, distal, with hemolytic anemia|Spherocytosis type 4","Pathogenic(Last reviewed: Feb 27, 2018)","criteria provided, multiple submitters, no conflicts","VCV000017773","17",42334882,"17",44257514,17773,32812,"rs28931584","NC_000017.11:44257513:C:T"
"NM_005450.5(NOG):c.103C>G (p.Pro35Ala)","NOG","P35A","Brachydactyly type B2","Pathogenic(Last reviewed: Aug 1, 2007)","no assertion criteria provided","VCV000006708","17",54671687,"17",56594326,6708,21747,"rs28937580","NC_000017.11:56594325:C:G"
"NM_005450.5(NOG):c.103C>T (p.Pro35Ser)","NOG","P35S","Symphalangism, proximal, 1A|Brachydactyly type B2|Stapes ankylosis with broad thumb and toes","Pathogenic(Last reviewed: Jul 1, 2008)","no assertion criteria provided","VCV000006703","17",54671687,"17",56594326,6703,21742,"rs28937580","NC_000017.11:56594325:C:T"
"NM_000304.4(PMP22):c.469C>T (p.Arg157Trp)","PMP22","R157W","Charcot-Marie-Tooth disease, type I|Hereditary liability to pressure palsies|Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease and deafness|PMP22-Related Disorders","Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2020)","criteria provided, conflicting interpretations","VCV000008444","17",15134248,"17",15230931,8444,23483,"rs28936682","NC_000017.11:15230930:G:A"
"NM_001614.5(ACTG1):c.611C>G (p.Ala204Gly)","ACTG1","A204G","Baraitser-Winter Syndrome 2|not provided","Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000452404","17",79478405,"17",81511379,452404,445921,"rs11549225","NC_000017.11:81511378:G:C"
"NM_007294.4(BRCA1):c.4039A>T (p.Arg1347Ter)","BRCA1","R1347*, R1300*","Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: May 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000531295","17",41243509,"17",43091492,531295,531245,"rs28897689","NC_000017.11:43091491:T:A"
"NM_000080.4(CHRNE):c.293T>C (p.Leu98Pro)","CHRNE|C17orf107","L98P","Myasthenic syndrome, congenital, 4a, slow-channel","Likely pathogenic(Last reviewed: Sep 22, 2019)","criteria provided, single submitter","VCV000534249","17",4805563,"17",4902268,534249,531399,"rs28929768","NC_000017.11:4902267:A:G"
"NM_001276697.2(TP53):c.-27C>G","TP53","P112A, P151A, P19A","Adenocarcinoma of stomach|Neoplasm of the large intestine|Carcinoma of esophagus|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenoid cystic carcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|Multiple myeloma|Hepatocellular carcinoma|Malignant melanoma of skin|Squamous cell lung carcinoma|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, single submitter","VCV000376641","17",7578479,"17",7675161,376641,363520,"rs28934874","NC_000017.11:7675160:G:C"
"NM_000304.4(PMP22):c.469C>G (p.Arg157Gly)","PMP22","R157G","Charcot-Marie-Tooth disease","Uncertain significance","no assertion criteria provided","VCV000637387","17",15134248,"17",15230931,637387,625362,"rs28936682","NC_000017.11:15230930:G:C"
"NM_001614.5(ACTG1):c.773C>T (p.Pro258Leu)","ACTG1","P258L","not provided|Deafness, autosomal dominant 20|Baraitser-Winter Syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000639093","17",79478243,"17",81511217,639093,646969,"rs11549191","NC_000017.11:81511216:G:A"
"NM_000546.5(TP53):c.844C>G (p.Arg282Gly)","TP53","R150G, R243G, R282G, R123G","Li-Fraumeni syndrome|Neoplasm of ovary|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Breast neoplasm|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Hepatocellular carcinoma|Neoplasm of brain|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Neoplasm of the large intestine|Glioblastoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Squamous cell lung carcinoma|Lung adenocarcinoma|Non-Hodgkin lymphoma|Pancreatic adenocarcinoma","Pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000140821","17",7577094,"17",7673776,140821,150535,"rs28934574","NC_000017.11:7673775:G:C"
"NM_000546.5(TP53):c.215= (p.Pro72=)","TP53","","not specified","Benign(Last reviewed: Aug 15, 2013)","criteria provided, single submitter","VCV000165560","17",7579472,"17",7676154,165560,176504,"rs1042522","NC_000017.11:7676153:G:G"
"NM_000180.4(GUCY2D):c.2511G>C (p.Glu837Asp)","GUCY2D","E837D","not provided","not provided","no assertion provided","VCV000098567","17",7918017,"17",8014699,98567,24393,"rs28933695","NC_000017.11:8014698:G:C"
"NM_000546.5(TP53):c.215C>A (p.Pro72His)","TP53","P33H, P72H","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1","Likely benign(Last reviewed: Apr 19, 2021)","reviewed by expert panel","VCV000185120","17",7579472,"17",7676154,185120,185405,"rs1042522","NC_000017.11:7676153:G:T"
"NM_001329877.1(FUT1):c.725T>G (p.Leu242Arg)","FUT1","L242R","BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype","Pathogenic, Affects(Last reviewed: Sep 8, 1997)","no assertion criteria provided","VCV000012142","19",49253814,"19",48750557,12142,27181,"rs28934588","NC_000019.10:48750556:A:C"
"NM_000540.3(RYR1):c.7304G>A (p.Arg2435His)","RYR1","R2435H","not provided|enflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|RYR1-Related Disorders|Central core myopathy|desflurane response - Toxicity/ADR","drug response","reviewed by expert panel","VCV000012966","19",38990637,"19",38499997,12966,28005,"rs28933396","NC_000019.10:38499996:G:A"
"NM_001972.4(ELANE):c.211T>C (p.Cys71Arg)","ELANE","C71R","Neutropenia, severe congenital 1, autosomal dominant","Pathogenic(Last reviewed: Nov 1, 2001)","no assertion criteria provided","VCV000016746","19",853019,"19",853019,16746,31785,"rs28931611","NC_000019.10:853018:T:C"
"NM_000041.4(APOE):c.388T>C (p.Cys130Arg)","APOE","C130R, C156R","Warfarin response|not provided|Alzheimer disease|Alzheimer disease, type 4|Alzheimer disease 2|Lipoprotein glomerulopathy|Primary degenerative dementia of the Alzheimer type, presenile onset","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Mar 24, 2020)","criteria provided, conflicting interpretations","VCV000017864","19",45411941,"19",44908684,17864,32903,"rs429358","NC_000019.10:44908683:T:C"
"NM_001285829.1(CEBPA):c.-107A>T","CEBPA","H84L, H119L, H70L","Acute myeloid leukemia","Pathogenic(Last reviewed: Mar 1, 2001)","no assertion criteria provided","VCV000017568","19",33793070,"19",33302164,17568,32607,"rs28931590","NC_000019.10:33302163:T:A"
"NM_000095.3(COMP):c.1418A>G (p.Asp473Gly)","COMP","D473G","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000009191","19",18896846,"19",18786036,9191,24230,"rs28936669","NC_000019.10:18786035:T:C"
"NM_000527.4(LDLR):c.1056C>T (p.Cys352=)","LDLR","","not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000413780","19",11221443,"19",11110767,413780,403134,"rs13306515","NC_000019.10:11110766:C:T"
"NM_014270.5(SLC7A9):c.411T>G (p.Cys137Trp)","SLC7A9","C137W","Cystinuria","Likely pathogenic(Last reviewed: Oct 17, 2019)","no assertion criteria provided","VCV000829904","19",33355069,"19",32864163,829904,818336,"rs12150890","NC_000019.10:32864162:A:C"
"NM_000041.4(APOE):c.388= (p.Cys130=)","APOE","","","no interpretation for the single variant","no interpretation for the single variant","VCV000694742","19",45411941,"19",44908684,694742,682795,"rs429358","NC_000019.10:44908683:T:T"
"NM_000540.2(RYR1):c.7304G>T (p.Arg2435Leu)","RYR1","R2435L","RYR1-Related Disorders|not provided","Pathogenic(Last reviewed: Apr 1, 2019)","criteria provided, single submitter","VCV000133196","19",38990637,"19",38499997,133196,136943,"rs28933396","NC_000019.10:38499996:G:T"
"NM_000146.4(FTL):c.163T>C (p.Leu55=)","FTL|GYS1","","sporadic abdominal aortic aneurysm|Hereditary hyperferritinemia with congenital cataracts|Neuroferritinopathy|Neuroferritinopathy|Hereditary hyperferritinemia with congenital cataracts|not specified|Glycogen storage disease 0, muscle|not provided","Benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000156440","19",49469087,"19",48965830,156440,166213,"rs2230267","NC_000019.10:48965829:T:C"
"NM_000527.5(LDLR):c.1056C>A (p.Cys352Ter)","LDLR","C352*, C184*, C225*, C311*","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)","criteria provided, multiple submitters, no conflicts","VCV000251621","19",11221443,"19",11110767,251621,245944,"rs13306515","NC_000019.10:11110766:C:A"
"NM_000527.5(LDLR):c.1056C>G (p.Cys352Trp)","LDLR","C352W, C184W, C225W, C311W","Familial hypercholesterolemia 1|Familial hypercholesterolemia","Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)","criteria provided, multiple submitters, no conflicts","VCV000251622","19",11221443,"19",11110767,251622,245945,"rs13306515","NC_000019.10:11110766:C:G"
"NM_014270.5(SLC7A9):c.411T>C (p.Cys137=)","SLC7A9","","Cystinuria|not provided","Benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000328762","19",33355069,"19",32864163,328762,348553,"rs12150890","NC_000019.10:32864162:A:G"
"NM_024407.5(NDUFS7):c.343C>T (p.Arg115Cys)","NDUFS7","R115C","not provided","Likely pathogenic(Last reviewed: Sep 25, 2014)","criteria provided, single submitter","VCV000214834","19",1390984,"19",1390985,214834,211859,"rs11551664","NC_000019.10:1390984:C:T"
"NM_000511.6(FUT2):c.604C>T (p.Arg202Ter)","FUT2|LOC105447645","R202*","Vitamin b12 plasma level quantitative trait locus 1|Familial Otitis Media","Pathogenic(Last reviewed: Mar 18, 2016)","criteria provided, single submitter","VCV000225366","19",49206817,"19",48703560,225366,227407,"rs1800028","NC_000019.10:48703559:C:T"
"NM_001267550.2(TTN):c.2219G>T (p.Arg740Leu)","TTN","R740L, R694L","Familial hypertrophic cardiomyopathy 9","Pathogenic(Last reviewed: Aug 27, 1999)","no assertion criteria provided","VCV000012649","2",179650726,"2",178785999,12649,27688,"rs28933405","NC_000002.12:178785998:C:A"
"NM_000104.4(CYP1B1):c.182G>A","CYP1B1","G61E","not provided|Glaucoma 3, primary congenital, A|Congenital glaucoma|Glaucoma 3, primary congenital, A|Glaucoma 3, primary infantile, b|Anterior segment dysgenesis 6|Anterior segment dysgenesis 6","Pathogenic(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000007730","2",38302350,"2",38075207,7730,22769,"rs28936700","NC_000002.12:38075206:C:T"
"NM_000104.3(CYP1B1):c.241T>A (p.Tyr81Asn)","CYP1B1","Y81N","not specified|not provided|Glaucoma 3, primary congenital, A|Primary open angle glaucoma|Congenital glaucoma|Congenital ocular coloboma|Irido-corneo-trabecular dysgenesis","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000007744","2",38302291,"2",38075148,7744,22783,"rs9282671","NC_000002.12:38075147:A:T"
"NM_194248.3(OTOF):c.5473C>G (p.Pro1825Ala)","OTOF","P1825A, P1135A, P1058A","Deafness, autosomal recessive 9","Pathogenic(Last reviewed: Apr 26, 2011)","no assertion criteria provided","VCV000006138","2",26684624,"2",26461756,6138,21177,"rs28937591","NC_000002.12:26461755:G:C"
"NM_000251.2(MSH2):c.1865C>T (p.Pro622Leu)","MSH2","P622L, P556L","Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000001753","2",47702269,"2",47475130,1753,16792,"rs28929483","NC_000002.12:47475129:C:T"
"NM_032976.3(CASP10):c.*327C>T","CASP10","A414V, A347V, A371V","Non-Hodgkin lymphoma","Pathogenic(Last reviewed: Jun 1, 2002)","no assertion criteria provided","VCV000007765","2",202074111,"2",201209388,7765,22804,"rs28936699","NC_000002.12:201209387:C:T"
"NM_000251.2(MSH2):c.1865C>A (p.Pro622Gln)","MSH2","P622Q, P556Q","not specified","Uncertain significance(Last reviewed: Nov 28, 2017)","criteria provided, single submitter","VCV000427606","2",47702269,"2",47475130,427606,416960,"rs28929483","NC_000002.12:47475129:C:A"
"NM_004304.5(ALK):c.4472A>G (p.Lys1491Arg)","ALK","K1491R, K423R","Hereditary cancer-predisposing syndrome|not specified|Squamous cell lung carcinoma|Neuroblastoma 3|not provided","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133474","2",29416481,"2",29193615,133474,137213,"rs1881420","NC_000002.12:29193614:T:C"
"NM_000251.2(MSH2):c.1865C>G (p.Pro622Arg)","MSH2","P622R, P556R","not specified|not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2018)","criteria provided, conflicting interpretations","VCV000265573","2",47702269,"2",47475130,265573,259740,"rs28929483","NC_000002.12:47475129:C:G"
"NM_000490.5(AVP):c.200T>C (p.Val67Ala)","AVP","V67A","Neurohypophyseal diabetes insipidus","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000012218","20",3063745,"20",3083099,12218,27257,"rs28934878","NC_000020.11:3083098:A:G"
"NM_000311.5(PRNP):c.385A>G (p.Met129Val)","PRNP","M129V","Prion disease, susceptibility to|Alzheimer disease, early-onset, susceptibility to|Aphasia, primary progressive, susceptibility to|not specified|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|Genetic prion disease","Benign/Likely benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013397","20",4680251,"20",4699605,13397,28436,"rs1799990","NC_000020.11:4699604:A:G"
"NM_000361.2(THBD):c.1483C>T (p.Pro495Ser)","THBD","P495S","Atypical hemolytic uremic syndrome|Atypical hemolytic-uremic syndrome 6|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 19, 2021)","criteria provided, conflicting interpretations","VCV000012720","20",23028659,"20",23048022,12720,27759,"rs1800578","NC_000020.11:23048021:G:A"
"NM_000516.6(GNAS):c.601C>T (p.Arg201Cys)","GNAS","R201C, R202C, R844C, R186C, R142C, R187C","Breast neoplasm|Neoplasm of the large intestine|Pancreatic adenocarcinoma|McCune-Albright syndrome|Hepatocellular carcinoma|Cushing syndrome|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Neoplasm of uterine cervix|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm|Sex cord-stromal tumor|Pituitary adenoma 3, multiple types","Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000015933","20",57484420,"20",58909365,15933,30972,"rs11554273","NC_000020.11:58909364:C:T"
"NM_000516.6(GNAS):c.601C>A (p.Arg201Ser)","GNAS","R201S, R202S, R187S, R142S, R186S, R844S","McCune-Albright syndrome|Cushing syndrome|Polyostotic fibrous dysplasia, somatic, mosaic|PITUITARY TUMOR 3, GROWTH HORMONE-SECRETING, SOMATIC","Pathogenic(Last reviewed: Jan 7, 2015)","no assertion criteria provided","VCV000015937","20",57484420,"20",58909365,15937,30976,"rs11554273","NC_000020.11:58909364:C:A"
"NM_000516.6(GNAS):c.601C>G (p.Arg201Gly)","GNAS","R201G, R202G, R844G, R186G, R142G, R187G","McCune-Albright syndrome","Pathogenic(Last reviewed: Jan 7, 2015)","no assertion criteria provided","VCV000015945","20",57484420,"20",58909365,15945,30984,"rs11554273","NC_000020.11:58909364:C:G"
"NM_000744.7(CHRNA4):c.851C>T (p.Ser284Leu)","CHRNA4","S284L, S108L","Autosomal dominant nocturnal frontal lobe epilepsy|Epilepsy, nocturnal frontal lobe, type 1|Seizures|not provided","Pathogenic(Last reviewed: Apr 13, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017500","20",61981912,"20",63350560,17500,32539,"rs28931591","NC_000020.11:63350559:G:A"
"NM_018848.3(MKKS):c.155G>A (p.Gly52Asp)","MKKS","G52D","Bardet-Biedl syndrome 6","Pathogenic(Last reviewed: Feb 12, 2018)","no assertion criteria provided","VCV000005311","20",10394008,"20",10413360,5311,20350,"rs28937875","NC_000020.11:10413359:C:T"
"NM_000557.5(GDF5):c.517A>G (p.Met173Val)","GDF5","M173V","Brachydactyly type C","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000008384","20",34025192,"20",35437412,8384,23423,"rs28936397","NC_000020.11:35437411:T:C"
"NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)","KCNE1","T7I","Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 2","Pathogenic(Last reviewed: Nov 1, 1997)","no assertion criteria provided","VCV000013476","21",35821913,"21",34449615,13476,28515,"rs28933384","NC_000021.9:34449614:G:A"
"NM_000071.2(CBS):c.1330G>A (p.Asp444Asn)","CBS","D444N, D339N","not provided|Homocystinuria|Classic homocystinuria|Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000126","21",44478972,"21",43058862,126,15165,"rs28934891","NC_000021.9:43058861:C:T"
"NM_000071.2(CBS):c.1265C>T (p.Pro422Leu)","CBS","P422L, P317L","Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","Uncertain significance(Last reviewed: Nov 26, 2018)","criteria provided, multiple submitters, no conflicts","VCV000000129","21",44479037,"21",43058927,129,15168,"rs28934892","NC_000021.9:43058926:G:A"
"NM_000211.5(ITGB2):c.1756C>T (p.Arg586Trp)","ITGB2","R586W, R517W","Leukocyte adhesion deficiency 1","Benign/Likely benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009463","21",46309312,"21",44889397,9463,24502,"rs5030672","NC_000021.9:44889396:G:A"
"NM_001347721.2(DYRK1A):c.450C>T (p.Tyr150=)","DYRK1A","","Mental retardation, autosomal dominant 7","Likely benign(Last reviewed: Nov 14, 2019)","criteria provided, single submitter","VCV000753666","21",38853089,"21",37480787,753666,773338,"rs1049773","NC_000021.9:37480786:C:T"
"NM_001953.5(TYMP):c.131G>A (p.Arg44Gln)","TYMP","R44Q","Mitochondrial DNA depletion syndrome 1 (MNGIE type)","Pathogenic(Last reviewed: Jan 14, 2016)","no assertion criteria provided","VCV000016661","22",50968008,"22",50529579,16661,31700,"rs28931613","NC_000022.11:50529578:C:T"
"NM_016335.5(PRODH):c.1322T>C (p.Leu441Pro)","PRODH","L441P, L333P","not provided|Schizophrenia 4|Proline dehydrogenase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000004008","22",18905934,"22",18918421,4008,19047,"rs2904551","NC_000022.11:18918420:A:G"
"NM_016335.5(PRODH):c.1292G>A (p.Arg431His)","PRODH","R431H, R323H","Proline dehydrogenase deficiency|Schizophrenia 4","Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000004011","22",18905964,"22",18918451,4011,19050,"rs2904552","NC_000022.11:18918450:C:T"
"NM_152299.4(NCAPH2):c.*526G>A","SCO2|NCAPH2","R171W","Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency","Pathogenic(Last reviewed: Mar 22, 2000)","no assertion criteria provided","VCV000005680","22",50962330,"22",50523901,5680,20719,"rs28937598","NC_000022.11:50523900:G:A"
"NM_001953.5(TYMP):c.1412C>T (p.Ser471Leu)","TYMP|SCO2","S471L, S476L","Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Fatal Infantile Cardioencephalomyopathy|not provided|not specified|none provided|Spinal muscular atrophy","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000130693","22",50964236,"22",50525807,130693,136139,"rs11479","NC_000022.11:50525806:G:A"
"NM_001953.5(TYMP):c.1412C>A (p.Ser471Ter)","TYMP|SCO2","S471*, S476*","Mitochondrial DNA depletion syndrome 1 (MNGIE type)","Pathogenic(Last reviewed: Jan 14, 2016)","no assertion criteria provided","VCV000223058","22",50964236,"22",50525807,223058,224783,"rs11479","NC_000022.11:50525806:G:T"
"NM_000174.4(GP9):c.167T>C (p.Leu56Pro)","GP9","L40P, L56P","Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000013532","3",128780749,"3",129061906,13532,28571,"rs28933377","NC_000003.12:129061905:T:C"
"NM_000539.3(RHO):c.632A>C (p.His211Pro)","RHO","H211P","Retinal dystrophy|Retinitis pigmentosa 4","Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013027","3",129251195,"3",129532352,13027,28066,"rs28933993","NC_000003.12:129532351:A:C"
"NM_000551.4(VHL):c.194C>G (p.Ser65Trp)","VHL","S65W","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043597","3",10183725,"3",10142041,43597,52766,"rs5030826","NC_000003.12:10142040:C:G"
"NM_000551.4(VHL):c.208G>A (p.Glu70Lys)","VHL","E70K","Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000043598","3",10183739,"3",10142055,43598,52767,"rs5030802","NC_000003.12:10142054:G:A"
"NM_020208.4(SLC6A20):c.596C>T (p.Thr199Met)","SLC6A20","T199M","Hyperglycinuria|Iminoglycinuria, digenic","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004845","3",45814094,"3",45772602,4845,19884,"rs17279437","NC_000003.12:45772601:G:A"
"NM_023067.4(FOXL2):c.251T>G (p.Ile84Ser)","FOXL2","I84S","Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1","Pathogenic(Last reviewed: Feb 1, 2003)","no assertion criteria provided","VCV000004863","3",138665314,"3",138946472,4863,19902,"rs28937884","NC_000003.12:138946471:A:C"
"NM_023067.4(FOXL2):c.772T>A (p.Tyr258Asn)","FOXL2","Y258N","Premature ovarian failure 3|Blepharophimosis, ptosis, and epicanthus inversus","Uncertain significance(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000004869","3",138664793,"3",138945951,4869,19908,"rs28937885","NC_000003.12:138945950:A:T"
"NM_000551.3(VHL):c.548C>A (p.Ser183Ter)","VHL|LOC107303340","S183*, S142*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Renal cell carcinoma, papillary, 1|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Mar 28, 2018)","criteria provided, single submitter","VCV000002215","3",10191555,"3",10149871,2215,17254,"rs5030823","NC_000003.12:10149870:C:A"
"NM_000551.3(VHL):c.292T>C (p.Tyr98His)","VHL","Y98H","Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002223","3",10183823,"3",10142139,2223,17262,"rs5030809","NC_000003.12:10142138:T:C"
"NM_000551.4(VHL):c.562C>G (p.Leu188Val)","VHL|LOC107303340","L188V, L147V","not provided|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Pheochromocytoma","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000002225","3",10191569,"3",10149885,2225,17264,"rs5030824","NC_000003.12:10149884:C:G"
"NM_000551.4(VHL):c.250G>T (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Mar 2, 2012)","criteria provided, single submitter","VCV000002236","3",10183781,"3",10142097,2236,17275,"rs5030827","NC_000003.12:10142096:G:T"
"NM_000551.3(VHL):c.277G>A (p.Gly93Ser)","VHL","G93S","Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Mar 20, 2018)","criteria provided, single submitter","VCV000002237","3",10183808,"3",10142124,2237,17276,"rs5030808","NC_000003.12:10142123:G:A"
"NM_198056.2(SCN5A):c.4931G>A (p.Arg1644His)","SCN5A","R1644H, R1643H, R1590H, R1611H, R1625H, R1626H","Congenital long QT syndrome|Long QT syndrome 3|not provided|Brugada syndrome|Cardiovascular phenotype","Pathogenic(Last reviewed: Mar 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009369","3",38592932,"3",38551441,9369,24408,"rs28937316","NC_000003.12:38551440:C:T"
"NM_000551.4(VHL):c.548C>T (p.Ser183Leu)","VHL|LOC107303340","S183L, S142L","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Uncertain significance(Last reviewed: Oct 9, 2020)","criteria provided, single submitter","VCV000411985","3",10191555,"3",10149871,411985,393224,"rs5030823","NC_000003.12:10149870:C:T"
"NM_000551.3(VHL):c.266T>A (p.Leu89His)","VHL","L89H","Renal cell carcinoma, papillary, 1","Likely pathogenic(Last reviewed: Jul 14, 2015)","no assertion criteria provided","VCV000376047","3",10183797,"3",10142113,376047,362926,"rs5030807","NC_000003.12:10142112:T:A"
"NM_000551.3(VHL):c.254T>C (p.Leu85Pro)","VHL","L85P","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Neoplasm","Uncertain significance(Last reviewed: Dec 19, 2019)","criteria provided, single submitter","VCV000376222","3",10183785,"3",10142101,376222,363101,"rs5030828","NC_000003.12:10142100:T:C"
"NM_000551.3(VHL):c.208G>T (p.Glu70Ter)","VHL","E70*","not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428806","3",10183739,"3",10142055,428806,420438,"rs5030802","NC_000003.12:10142054:G:T"
"NM_000551.3(VHL):c.250G>A (p.Val84Met)","VHL","V84M","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2019)","criteria provided, conflicting interpretations","VCV000428813","3",10183781,"3",10142097,428813,420439,"rs5030827","NC_000003.12:10142096:G:A"
"NM_000551.3(VHL):c.280G>T (p.Glu94Ter)","VHL","E94*","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000584477","3",10183811,"3",10142127,584477,575529,"rs5030829","NC_000003.12:10142126:G:T"
"NM_000551.3(VHL):c.239G>T (p.Ser80Ile)","VHL","S80I","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: May 2, 2019)","criteria provided, multiple submitters, no conflicts","VCV000625229","3",10183770,"3",10142086,625229,613562,"rs5030805","NC_000003.12:10142085:G:T"
"NM_000551.3(VHL):c.280G>A (p.Glu94Lys)","VHL","E94K","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: Apr 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000135955","3",10183811,"3",10142127,135955,139667,"rs5030829","NC_000003.12:10142126:G:A"
"NM_000551.3(VHL):c.194C>T (p.Ser65Leu)","VHL","S65L","Pancreatic cysts|Cerebellar hemangioblastoma|Retinal capillary hemangioma|Spinal hemangioblastoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182975","3",10183725,"3",10142041,182975,180112,"rs5030826","NC_000003.12:10142040:C:T"
"NM_000551.3(VHL):c.266T>C (p.Leu89Pro)","VHL","L89P","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)","criteria provided, multiple submitters, no conflicts","VCV000182979","3",10183797,"3",10142113,182979,180117,"rs5030807","NC_000003.12:10142112:T:C"
"NM_000551.3(VHL):c.250G>C (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Mar 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000229860","3",10183781,"3",10142097,229860,232861,"rs5030827","NC_000003.12:10142096:G:C"
"NM_000551.3(VHL):c.548C>G (p.Ser183Trp)","VHL|LOC107303340","S183W, S142W","Pheochromocytoma","Likely pathogenic(Last reviewed: Dec 1, 2015)","no assertion criteria provided","VCV000219158","3",10191555,"3",10149871,219158,217071,"rs5030823","NC_000003.12:10149870:C:G"
"NM_000551.3(VHL):c.194C>A (p.Ser65Ter)","VHL","S65*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Sep 23, 2019)","criteria provided, single submitter","VCV000223161","3",10183725,"3",10142041,223161,224892,"rs5030826","NC_000003.12:10142040:C:A"
"NM_000551.3(VHL):c.277G>C (p.Gly93Arg)","VHL","G93R","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Uncertain significance(Last reviewed: Jan 29, 2019)","criteria provided, single submitter","VCV000223174","3",10183808,"3",10142124,223174,224905,"rs5030808","NC_000003.12:10142123:G:C"
"NM_000551.3(VHL):c.277G>T (p.Gly93Cys)","VHL","G93C","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 26, 2016)","no assertion criteria provided","VCV000223175","3",10183808,"3",10142124,223175,224906,"rs5030808","NC_000003.12:10142123:G:T"
"NM_000551.3(VHL):c.486C>A (p.Cys162Ter)","VHL|LOC107303340","C162*, C121*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 25, 2019)","criteria provided, single submitter","VCV000223226","3",10191493,"3",10149809,223226,224956,"rs5030622","NC_000003.12:10149808:C:A"
"NM_000551.3(VHL):c.486C>G (p.Cys162Trp)","VHL|LOC107303340","C162W, C121W","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)","criteria provided, conflicting interpretations","VCV000223227","3",10191493,"3",10149809,223227,224957,"rs5030622","NC_000003.12:10149808:C:G"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4",4861877,"4",4860150,14883,29922,"rs28928890","NC_000004.12:4860149:A:T"
"NM_000128.3(F11):c.976C>T (p.Arg326Cys)","F11","R326C","Hereditary factor XI deficiency disease","Likely pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011898","4",187201487,"4",186280333,11898,26937,"rs28934608","NC_000004.12:186280332:C:T"
"NM_000128.3(F11):c.1782C>A (p.Ser594Arg)","F11|F11-AS1","S594R","Hereditary factor XI deficiency disease","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011900","4",187209672,"4",186288518,11900,26939,"rs28934609","NC_000004.12:186288517:C:A"
"NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)","FGFR3","P250R","Craniosynostosis syndrome|not specified|not provided|Saethre-Chotzen syndrome|Muenke syndrome|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|Coronal craniosynostosis|Crouzon syndrome|Facial asymmetry|Infantile axial hypotonia|Absence seizures|Unilateral renal agenesis|Seizures","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016340","4",1803571,"4",1801844,16340,31379,"rs4647924","NC_000004.12:1801843:C:G"
"NM_000142.5(FGFR3):c.749C>T (p.Pro250Leu)","FGFR3","P250L","Craniosynostosis syndrome","Uncertain significance(Last reviewed: Oct 2, 2017)","criteria provided, single submitter","VCV000533893","4",1803571,"4",1801844,533893,519844,"rs4647924","NC_000004.12:1801843:C:T"
"NM_000203.5(IDUA):c.1403-1G>T","IDUA","","Mucopolysaccharidosis type 1","Likely pathogenic(Last reviewed: Dec 21, 2018)","criteria provided, single submitter","VCV000652306","4",996823,"4",1003035,652306,651143,"rs4690223","NC_000004.12:1003034:G:T"
"NM_000203.5(IDUA):c.1225G>C (p.Gly409Arg)","IDUA","G409R, G277R","not provided|not specified|Mucopolysaccharidosis type 1|Hurler syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)","criteria provided, conflicting interpretations","VCV000092627","4",996555,"4",1002767,92627,26950,"rs11934801","NC_000004.12:1002766:G:C"
"NM_000325.6(PITX2):c.*454C>T","PITX2","","PITX2-Related Eye Abnormalities|Irido-corneo-trabecular dysgenesis|Cataract (disease)|not provided|Axenfeld-Rieger syndrome type 1|Ring dermoid of cornea|Anterior segment dysgenesis 1|Hypoplasia of the iris","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000183253","4",111538827,"4",110617671,183253,181382,"rs6533526","NC_000004.12:110617670:G:A"
"NM_000521.3(HEXB):c.185C>T (p.Ser62Leu)","HEXB","","Sandhoff disease, infantile type|Sandhoff disease","Benign(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000003882","5",73981270,"5",74685445,3882,18921,"rs820878","NC_000005.10:74685444:T:T"
"NM_014402.5(UQCRQ):c.134C>T (p.Ser45Phe)","UQCRQ","S45F","not provided|Mitochondrial complex III deficiency, nuclear type 4","Pathogenic(Last reviewed: Jun 16, 2015)","criteria provided, single submitter","VCV000000729","5",132202707,"5",132867015,729,15768,"rs11544803","NC_000005.10:132867014:C:T"
"NM_004168.4(SDHA):c.1660C>T (p.Arg554Trp)","SDHA","R554W, R506W","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Leigh syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)","criteria provided, conflicting interpretations","VCV000008742","5",251215,"5",251100,8742,23781,"rs9809219","NC_000005.10:251099:C:T"
"NM_000521.4(HEXB):c.185T>C (p.Leu62Ser)","HEXB","L62S","not specified|Sandhoff disease","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000167173","5",73981270,"5",74685445,167173,177767,"rs820878","NC_000005.10:74685444:T:C"
"NM_000500.9(CYP21A2):c.713T>A (p.Val238Glu)","CYP21A2|LOC106780800","V238E, V103E, V208E","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000012173","6",32007587,"6",32039810,12173,27212,"rs12530380","NC_000006.12:32039809:T:A"
"NM_000500.9(CYP21A2):c.1069C>T (p.Arg357Trp)","CYP21A2|TNXB|LOC106780800","R357W, R327W, R222W","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Aug 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012152","6",32008312,"6",32040535,12152,27191,"rs7769409","NC_000006.12:32040534:C:T"
"NM_000500.9(CYP21A2):c.1360C>T (p.Pro454Ser)","CYP21A2|LOC106780800","P454S, P424S, P319S","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Oct 31, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012159","6",32008783,"6",32041006,12159,27198,"rs6445","NC_000006.12:32041005:C:T"
"NM_000500.7(CYP21A2):c.955C>T (p.Gln319Ter)","CYP21A2|TNXB|LOC106780800","Q319*, Q289*, Q184*","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: May 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012169","6",32008198,"6",32040421,12169,27208,"rs7755898|rs6445","NC_000006.12:32040420:C:T"
"NM_004415.4(DSP):c.7096C>T (p.Arg2366Cys)","DSP","R2366C, R1767C, R1923C","Skin fragility-woolly hair-palmoplantar keratoderma syndrome|not specified","Uncertain significance(Last reviewed: Jun 16, 2016)","criteria provided, single submitter","VCV000016841","6",7584591,"6",7584358,16841,31880,"rs28931610","NC_000006.12:7584357:C:T"
"NM_000410.3(HFE):c.845G>A (p.Cys282Tyr)","HFE","C282Y, C176Y, C180Y, C190Y, C194Y, C259Y, C268Y, C102Y","Hereditary cancer-predisposing syndrome|Porphyria variegata, susceptibility to|Hemochromatosis, juvenile, digenic|Alzheimer disease, susceptibility to|Transferrin serum level quantitative trait locus 2|Microvascular complications of diabetes 7|Alzheimer disease|Porphyrinuria|Cutaneous photosensitivity|not provided|Hemochromatosis type 2|Hemochromatosis type 1|Porphyria cutanea tarda, susceptibility to|Abdominal pain|Pain|Peripheral neuropathy|Abnormality of the male genitalia|Abnormal peripheral nervous system morphology|Abnormality of the nervous system|Behavioral abnormality|Bronze diabetes|Hereditary hemochromatosis","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: May 1, 2021)","criteria provided, conflicting interpretations","VCV000000009","6",26093141,"6",26092913,9,15048,"rs1800562","NC_000006.12:26092912:G:A"
"NM_138272.2(MPIG6B):c.523C>T (p.Arg175Ter)","MPIG6B","R175*","not provided","Pathogenic(Last reviewed: Dec 27, 2018)","criteria provided, single submitter","VCV000660958","6",31692386,"6",31724609,660958,634804,"rs11575845","NC_000006.12:31724608:C:T"
"NM_001453.3(FOXC1):c.405C>T (p.Cys135=)","FOXC1","","not specified|not provided|Axenfeld-Rieger syndrome type 3","Benign(Last reviewed: Nov 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000167085","6",1611085,"6",1610850,167085,177717,"rs2230096","NC_000006.12:1610849:C:T"
"NM_000500.9(CYP21A2):c.719T>A (p.Met240Lys)","CYP21A2|LOC106780800","M240K, M105K, M210K","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000242688","6",32007593,"6",32039816,242688,40032,"rs6476","NC_000006.12:32039815:T:A"
"NM_148919.4(PSMB8):c.145C>A (p.Gln49Lys)","PSMB8","Q49K","not specified|Proteasome-associated autoinflammatory syndrome 1","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000356368","6",32811629,"6",32843852,356368,302501,"rs2071543","NC_000006.12:32843851:G:T"
"NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)","GLI3","A934P","Greig cephalopolysyndactyly syndrome, severe","Pathogenic(Last reviewed: Jun 1, 2006)","no assertion criteria provided","VCV000013825","7",42005871,"7",41966273,13825,28864,"rs28933372","NC_000007.14:41966272:C:G"
"NM_172056.2(KCNH2):c.1468G>A (p.Ala490Thr)","KCNH2","A490T, A150T","not provided|Long QT syndrome|Long QT syndrome, bradycardia-induced|Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Sep 21, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014430","7",150649602,"7",150952514,14430,29469,"rs28928905","NC_000007.14:150952513:C:T"
"NM_000420.3(KEL):c.1790T>C (p.Leu597Pro)","KEL","L597P","not provided|Kel6 antigen","Benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000031082","7",142640113,"7",142943026,31082,40039,"rs8176038","NC_000007.14:142943025:A:G"
"NM_000492.4(CFTR):c.224G>A (p.Arg75Gln)","CFTR","R75Q","Hereditary pancreatitis|Cystic fibrosis|not specified|not provided|Abnormality of the pancreas|CFTR-related disorders|Inborn genetic diseases|Lung disease, non-specific|none provided","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000035839","7",117149147,"7",117509093,35839,44503,"rs1800076","NC_000007.14:117509092:G:A"
"NM_000941.3(POR):c.1475T>A (p.Val492Glu)","POR","V492E","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000016901","7",75614973,"7",75985655,16901,31940,"rs28931606","NC_000007.14:75985654:T:A"
"NM_000941.3(POR):c.1706G>A (p.Cys569Tyr)","POR","C569Y","Congenital adrenal hyperplasia|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency","Likely pathogenic(Last reviewed: Jul 20, 2021)","criteria provided, single submitter","VCV000016903","7",75615277,"7",75985959,16903,31942,"rs28931607","NC_000007.14:75985958:G:A"
"NM_000823.4(GHRHR):c.57+1G>A","GHRHR","","Isolated growth hormone deficiency, type 4","Pathogenic(Last reviewed: Dec 1, 2007)","no assertion criteria provided","VCV000015990","7",31003741,"7",30964126,15990,31029,"rs2302022","NC_000007.14:30964125:G:A"
"NM_001098629.3(IRF5):c.-12+198=","IRF5","","Systemic lupus erythematosus 10|Rheumatoid arthritis","Pathogenic, risk factor(Last reviewed: Mar 15, 2008)","no assertion criteria provided","VCV000003396","7",128578301,"7",128938247,3396,18435,"rs2004640","NC_000007.14:128938246:T:T"
"NM_000492.3(CFTR):c.4272C>A (p.Tyr1424Ter)","CFTR|LOC111674477","Y1424*","Cystic fibrosis","Pathogenic/Likely pathogenic(Last reviewed: May 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000555210","7",117306991,"7",117666937,555210,544496,"rs1800135","NC_000007.14:117666936:C:A"
"NM_172056.2(KCNH2):c.1468G>C (p.Ala490Pro)","KCNH2","A150P, A490P","Congenital long QT syndrome","not provided","no assertion provided","VCV000067202","7",150649602,"7",150952514,67202,78098,"rs28928905","NC_000007.14:150952513:C:G"
"NM_000492.3(CFTR):c.224G>T (p.Arg75Leu)","CFTR","R75L","Cystic fibrosis|not specified","Uncertain significance(Last reviewed: Apr 10, 2019)","criteria provided, single submitter","VCV000053461","7",117149147,"7",117509093,53461,68129,"rs1800076","NC_000007.14:117509092:G:T"
"NM_000492.3(CFTR):c.4272C>T (p.Tyr1424=)","CFTR|LOC111674477","","none provided|CFTR-related disorders|not specified|Cystic fibrosis|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000093156","7",117306991,"7",117666937,93156,99063,"rs1800135","NC_000007.14:117666936:C:T"
"NM_000823.4(GHRHR):c.57+1G>T","GHRHR","","Isolated growth hormone deficiency type IB","Uncertain significance(Last reviewed: Sep 28, 2016)","criteria provided, single submitter","VCV000360028","7",31003741,"7",30964126,360028,310914,"rs2302022","NC_000007.14:30964125:G:T"
"NM_000492.3(CFTR):c.4272C>G (p.Tyr1424Ter)","CFTR|LOC111674477","Y1424*","not specified|Cystic fibrosis","Likely pathogenic(Last reviewed: Nov 5, 2018)","criteria provided, multiple submitters, no conflicts","VCV000371349","7",117306991,"7",117666937,371349,357584,"rs1800135","NC_000007.14:117666936:C:G"
"NM_000492.4(CFTR):c.2900T>C (p.Leu967Ser)","CFTR","L967S","Cystic fibrosis|none provided|CFTR-related disorders|Inborn genetic diseases|not specified|not provided|Infertility","Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2021)","criteria provided, conflicting interpretations","VCV000219537","7",117243828,"7",117603774,219537,221666,"rs1800110","NC_000007.14:117603773:T:C"
"NM_006158.5(NEFL):c.64C>T (p.Pro22Ser)","NEFL","P22S","Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|Peripheral demyelination|Hand muscle atrophy|Distal muscle weakness|Peripheral neuropathy|Decreased nerve conduction velocity|not provided|Peripheral neuropathy|Distal lower limb muscle weakness|Pes cavus|Charcot-Marie-Tooth disease, type 1C","Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014029","8",24813966,"8",24956452,14029,29068,"rs28928910","NC_000008.11:24956451:G:A"
"NM_006158.4(NEFL):c.64C>A (p.Pro22Thr)","NEFL","P22T","Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided","Pathogenic(Last reviewed: Oct 18, 2012)","no assertion criteria provided","VCV000041238","8",24813966,"8",24956452,41238,49662,"rs28928910","NC_000008.11:24956451:G:T"
"NM_002052.5(GATA4):c.1129A>G (p.Ser377Gly)","GATA4","S377G, S378G, S171G","Atrioventricular septal defect 4|Cardiovascular phenotype|not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000044334","8",11614575,"8",11757066,44334,53501,"rs3729856","NC_000008.11:11757065:A:G"
"NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004602","8",143822617,"8",142741199,4602,19641,"rs28937888","NC_000008.11:142741198:C:T"
"NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004603","8",143822617,"8",142741199,4603,19642,"rs28937888","NC_000008.11:142741198:C:G"
"NM_000031.6(ALAD):c.177G>C (p.Lys59Asn)","ALAD","K59N, K51N, K88N","not provided|Porphobilinogen synthase deficiency|AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016864","9",116153891,"9",113391611,16864,31903,"rs1800435","NC_000009.12:113391610:C:G"
"NM_003995.3(NPR2):c.528T>A (p.Asp176Glu)","NPR2","D176E","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017786","9",35792933,"9",35792936,17786,32825,"rs28929479","NC_000009.12:35792935:T:A"
"NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)","ABCA1","N935S","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009488","9",107584801,"9",104822520,9488,24527,"rs28937313","NC_000009.12:104822519:T:C"
"NM_005502.4(ABCA1):c.2803A>C (p.Asn935His)","ABCA1","N935H","Tangier disease","Pathogenic(Last reviewed: Jan 1, 2002)","no assertion criteria provided","VCV000009498","9",107584802,"9",104822521,9498,24537,"rs28937314","NC_000009.12:104822520:T:G"
"NM_000077.4(CDKN2A):c.242C>G (p.Pro81Arg)","CDKN2A","P81R, P30R","Hereditary melanoma|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2019)","criteria provided, conflicting interpretations","VCV000463492","9",21971116,"9",21971117,463492,459469,"rs11552823","NC_000009.12:21971116:G:C"
"NM_000077.4(CDKN2A):c.250G>T (p.Asp84Tyr)","CDKN2A","D84Y, R98L, D33Y","Neoplasm|Hereditary cancer-predisposing syndrome|Hereditary melanoma","Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2020)","criteria provided, conflicting interpretations","VCV000376306","9",21971108,"9",21971109,376306,363185,"rs11552822","NC_000009.12:21971108:C:A"
"NM_005502.4(ABCA1):c.1759C>T (p.Arg587Trp)","ABCA1","R587W","ABCA1-Related Disorders","Pathogenic(Last reviewed: Jan 11, 2019)","criteria provided, single submitter","VCV000632033","9",107593339,"9",104831058,632033,620315,"rs2853574","NC_000009.12:104831057:G:A"
"NM_005502.4(ABCA1):c.2803A>G (p.Asn935Asp)","ABCA1","N935D","Tangier disease","Likely pathogenic(Last reviewed: May 1, 2016)","no assertion criteria provided","VCV000374312","9",107584802,"9",104822521,374312,361192,"rs28937314","NC_000009.12:104822520:T:C"
"NM_004629.1(FANCG):c.1538G>A (p.Arg513Gln)","FANCG|VCP","R513Q","not provided|not specified|Fanconi anemia, complementation group G|Amyotrophic Lateral Sclerosis, Dominant|Fanconi anemia|Inclusion Body Myopathy, Dominant","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000134361","9",35075022,"9",35075025,134361,138100,"rs17885240","NC_000009.12:35075024:C:T"
"NM_139025.4(ADAMTS13):c.1342C>G (p.Gln448Glu)","ADAMTS13","Q448E, Q417E","Upshaw-Schulman syndrome|not specified","Benign(Last reviewed: Jun 14, 2016)","criteria provided, multiple submitters, no conflicts","VCV000242806","9",136301982,"9",133436862,242806,20852,"rs2301612","NC_000009.12:133436861:C:G"
"NM_000077.4(CDKN2A):c.250G>A (p.Asp84Asn)","CDKN2A","D84N, R98Q, D33N","Hereditary melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2019)","criteria provided, conflicting interpretations","VCV000229806","9",21971108,"9",21971109,229806,233753,"rs11552822","NC_000009.12:21971108:C:T"
"NM_000402.4(G6PD):c.632A>T (p.Asp211Val)","G6PD","D181V, D211V","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD MALAGA","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000037203","X",153762655,"X",154534440,37203,25421,"rs5030872","NC_000023.11:154534439:T:A"
"NM_001110792.2(MECP2):c.455C>T (p.Ala152Val)","MECP2","A140V, A152V, A47V","Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided|Severe neonatal-onset encephalopathy with microcephaly|Behavioral abnormality|Intellectual disability|Rett syndrome|Motor delay|Intellectual disability|Postnatal growth retardation|Microcephaly|Downslanted palpebral fissures|Micrognathia|Stenosis of the external auditory canal|Hearing impairment|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Neurodevelopmental disorder","Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011823","X",153296860,"X",154031409,11823,26862,"rs28934908","NC_000023.11:154031408:G:A"
"NM_000032.5(ALAS2):c.569A>T (p.Asp190Val)","ALAS2","D190V, D177V, D153V","Anemia, hereditary sideroblastic 1, pyridoxine refractory","Pathogenic(Last reviewed: Jul 15, 1997)","no assertion criteria provided","VCV000010474","X",55047554,"X",55021121,10474,25513,"rs28935484","NC_000023.11:55021120:T:A"
"NM_000044.6(AR):c.2522G>A (p.Arg841His)","AR","R309H, R841H","Androgen resistance syndrome|not provided|Androgen resistance syndrome|Kennedy disease|Partial androgen insensitivity syndrome","Pathogenic(Last reviewed: Sep 10, 2019)","criteria provided, multiple submitters, no conflicts","VCV000009829","X",66942741,"X",67722899,9829,24868,"rs9332969","NC_000023.11:67722898:G:A"
"NM_000132.3(F8):c.1331A>G (p.Lys444Arg)","F8","K444R","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Aug 15, 1991)","no assertion criteria provided","VCV000010212","X",154194357,"X",154966082,10212,25251,"rs28937272","NC_000023.11:154966081:T:C"
"NM_004429.4(EFNB1):c.472A>G (p.Met158Val)","EFNB1","M158V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011711","X",68059572,"X",68839729,11711,26750,"rs28936071","NC_000023.11:68839728:A:G"
"NM_004429.4(EFNB1):c.452G>T (p.Gly151Val)","EFNB1","G151V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011710","X",68059552,"X",68839709,11710,26749,"rs28936070","NC_000023.11:68839708:G:T"
"NM_004429.4(EFNB1):c.474G>T (p.Met158Ile)","EFNB1","M158I","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011712","X",68059574,"X",68839731,11712,26751,"rs28935170","NC_000023.11:68839730:G:T"
"NM_001110556.2(FLNA):c.3476A>C (p.Asp1159Ala)","FLNA","D1159A","Frontometaphyseal dysplasia 1","Pathogenic(Last reviewed: Jan 5, 2018)","no assertion criteria provided","VCV000011757","X",153588687,"X",154360319,11757,26796,"rs28935471","NC_000023.11:154360318:T:G"
"NM_001110556.2(FLNA):c.3562G>A (p.Ala1188Thr)","FLNA","A1188T","not provided|Melnick-Needles syndrome","Pathogenic(Last reviewed: Oct 12, 2017)","criteria provided, single submitter","VCV000011758","X",153588601,"X",154360233,11758,26797,"rs28935472","NC_000023.11:154360232:C:T"
"NM_001110556.2(FLNA):c.3596C>T (p.Ser1199Leu)","FLNA","S1199L","Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Melnick-Needles syndrome|Frontometaphyseal dysplasia|Periventricular nodular heterotopia 1|Oto-palato-digital syndrome, type II","Pathogenic(Last reviewed: Dec 23, 2016)","criteria provided, multiple submitters, no conflicts","VCV000011759","X",153588567,"X",154360199,11759,26798,"rs28935473","NC_000023.11:154360198:G:A"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2561C>G","GLA|RPL36A-HNRNPH2","G361R","Fabry disease","Pathogenic(Last reviewed: Jul 1, 1993)","no assertion criteria provided","VCV000010744","X",100653006,"X",101398018,10744,25783,"rs28935494","NC_000023.11:101398017:C:G"
"NM_000475.5(NR0B1):c.873G>C (p.Trp291Cys)","NR0B1","W291C","Congenital adrenal hypoplasia, X-linked","Pathogenic(Last reviewed: Nov 1, 1997)","no assertion criteria provided","VCV000010965","X",30326608,"X",30308491,10965,26004,"rs28935482","NC_000023.11:30308490:C:G"
"NM_001145252.3(CFP):c.893G>T (p.Gly298Val)","CFP","G298V","Properdin deficiency, X-linked","Pathogenic(Last reviewed: Jul 1, 2000)","no assertion criteria provided","VCV000011183","X",47486219,"X",47626820,11183,26222,"rs28935480","NC_000023.11:47626819:C:A"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X",25033757,"X",25015640,11198,26237,"rs28936077","NC_000023.11:25015639:A:G"
"NM_139058.3(ARX):c.856G>A (p.Gly286Ser)","ARX","G286S","Mental retardation, with or without seizures, ARX-related, X-linked|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000011199","X",25031256,"X",25013139,11199,26238,"rs28935479","NC_000023.11:25013138:C:T"
"NM_000044.6(AR):c.2528T>C (p.Ile843Thr)","AR","I843T, I311T","Kennedy disease|Androgen resistance syndrome","Pathogenic(Last reviewed: Nov 30, 2018)","criteria provided, single submitter","VCV000658124","X",66942747,"X",67722905,658124,650153,"rs9332970","NC_000023.11:67722904:T:C"
"NM_014009.4(FOXP3):c.155G>T (p.Gly52Val)","FOXP3","G52V","Non-obstructive azoospermia|Insulin-dependent diabetes mellitus secretory diarrhea syndrome","Benign(Last reviewed: Nov 23, 2020)","criteria provided, single submitter","VCV000712945","X",49114808,"X",49258351,712945,729636,"rs17847095","NC_000023.11:49258350:C:A"
"NM_000169.2(GLA):c.1081G>A (p.Gly361Arg)","GLA|RPL36A-HNRNPH2","G361R","not provided","Pathogenic(Last reviewed: Apr 23, 2015)","criteria provided, single submitter","VCV000245750","X",100653006,"X",101398018,245750,245170,"rs28935494","NC_000023.11:101398017:C:T"
"NM_170707.4(LMNA):c.178C>G (p.Arg60Gly)","LMNA","R60G","not provided|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Aug 27, 2002)","no assertion criteria provided","VCV000014479","1",156084887,"1",156115096,14479,29518,"rs28928900","NC_000001.11:156115095:C:G"
"NM_000702.4(ATP1A2):c.2066G>A (p.Arg689Gln)","ATP1A2","R689Q","not provided|Familial hemiplegic migraine type 2","Likely pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, single submitter","VCV000012920","1",160105036,"1",160135246,12920,27959,"rs28933401","NC_000001.11:160135245:G:A"
"NM_000488.3(SERPINC1):c.89T>A (p.Val30Glu)","SERPINC1","","not provided|Deep venous thrombosis|Thromboembolism|Antithrombin III deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)","criteria provided, conflicting interpretations","VCV000018012","1",173884010,"1",173914872,18012,33051,"rs2227624","NC_000001.11:173914871:A:T"
"NM_001002294.3(FMO3):c.923A>G (p.Glu308Gly)","FMO3","E308G, E245G, E288G","Trimethylaminuria|not specified","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000038395","1",171083242,"1",171114102,38395,31357,"rs2266780","NC_000001.11:171114101:A:G"
"NM_000157.4(GBA):c.259C>T (p.Arg87Trp)","GBA|LOC106627981","R87W","Gaucher disease|Gaucher disease type I|not provided","Pathogenic(Last reviewed: Feb 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004321","1",155209725,"1",155239934,4321,19360,"rs1141814","NC_000001.11:155239933:G:A"
"NM_174936.3(PCSK9):c.2037C>A (p.Cys679Ter)","PCSK9","C679*","Familial hypercholesterolemia|not provided|Low density lipoprotein cholesterol level quantitative trait locus 1|Familial hypercholesterolemia 3|Hypocholesterolemia","Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2021)","criteria provided, conflicting interpretations","VCV000002877","1",55529215,"1",55063542,2877,17916,"rs28362286","NC_000001.11:55063541:C:A"
"NM_000098.3(CPT2):c.1657G>A (p.Asp553Asn)","CPT2","D553N, D530N","Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile","Uncertain significance(Last reviewed: May 10, 2018)","criteria provided, single submitter","VCV000008955","1",53678947,"1",53213275,8955,23994,"rs28936376","NC_000001.11:53213274:G:A"
"NM_005026.5(PIK3CD):c.1002C>T (p.Asn334=)","PIK3CD","","Immunodeficiency 14","Benign(Last reviewed: Dec 2, 2020)","criteria provided, single submitter","VCV000541092","1",9777666,"1",9717608,541092,516098,"rs28730670","NC_000001.11:9717607:C:T"
"NM_000350.3(ABCA4):c.6319C>A (p.Arg2107Ser)","ABCA4","R2107S","not provided","Uncertain significance(Last reviewed: Nov 21, 2016)","criteria provided, single submitter","VCV000497254","1",94466625,"1",94001069,497254,488678,"rs2297669","NC_000001.11:94001068:G:T"
"NR_040073.1(MIR181A1HG):n.364-18748G>A","MIR181A1HG","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427753","1",198796120,"1",198826991,427753,417642,"rs12406470","NC_000001.11:198826990:C:T"
"NM_000350.3(ABCA4):c.6319C>T (p.Arg2107Cys)","ABCA4","R2107C","Retinal dystrophy|Stargardt disease|not provided","Pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000635988","1",94466625,"1",94001069,635988,623815,"rs2297669","NC_000001.11:94001068:G:A"
"NM_015602.3(TOR1AIP1):c.961C>T (p.Arg321Ter)","TOR1AIP1","R321*, R322*","Muscular dystrophy, limb-girdle, type 2y","Likely pathogenic(Last reviewed: Jun 20, 2019)","criteria provided, single submitter","VCV000804380","1",179883186,"1",179914051,804380,792713,"rs11581962","NC_000001.11:179914050:C:T"
"NM_005026.5(PIK3CD):c.1002C>G (p.Asn334Lys)","PIK3CD","N334K, N305K","Immunodeficiency 14","Uncertain significance(Last reviewed: May 1, 2018)","criteria provided, single submitter","VCV000578525","1",9777666,"1",9717608,578525,558601,"rs28730670","NC_000001.11:9717607:C:G"
"NM_005026.5(PIK3CD):c.1002C>A (p.Asn334Lys)","PIK3CD","N334K, N305K","Immunodeficiency 14","Pathogenic(Last reviewed: Jan 1, 2014)","no assertion criteria provided","VCV000132806","1",9777666,"1",9717608,132806,136555,"rs28730670","NC_000001.11:9717607:C:A"
"NM_170707.4(LMNA):c.178C>T (p.Arg60Cys)","LMNA","R60C","Charcot-Marie-Tooth disease, type 2|not specified|Cardiomyopathy","Uncertain significance(Last reviewed: Jun 5, 2019)","criteria provided, multiple submitters, no conflicts","VCV000179969","1",156084887,"1",156115096,179969,172341,"rs28928900","NC_000001.11:156115095:C:T"
"NM_003126.4(SPTA1):c.6531-12C>T","SPTA1","","Hemolytic anemia|Elliptocytosis 2|Hereditary pyropoikilocytosis|not specified|Spherocytosis type 3","Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2019)","criteria provided, conflicting interpretations","VCV000258954","1",158587858,"1",158618068,258954,249428,"rs28525570","NC_000001.11:158618067:G:A"
"NM_003126.4(SPTA1):c.6549-12G>A","SPTA1","","Hemolytic anemia|Elliptocytosis 2|Hereditary pyropoikilocytosis|not specified|Spherocytosis type 3","Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2019)","criteria provided, conflicting interpretations","VCV000258955","1",158587390,"1",158617600,258955,249427,"rs857716","NC_000001.11:158617599:C:T"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1",94506910,"1",94041354,236101,237679,"rs1047376","NC_000001.11:94041353:A:G"
"NM_014625.3(NPHS2):c.-51G>T","NPHS2","","Idiopathic nephrotic syndrome|not provided|not specified","Benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000225144","1",179545050,"1",179575915,225144,227036,"rs12406197","NC_000001.11:179575914:C:A"
"NM_001378373.1(MBL2):c.161G>A (p.Gly54Asp)","MBL2","","Mannose-binding protein deficiency","Pathogenic(Last reviewed: Oct 1, 2004)","no assertion criteria provided","VCV000014350","10",54531235,"10",52771475,14350,29389,"rs1800450","NC_000010.11:52771474:C:T"
"CYP2C19*4A/*22","CYP2C19","R186P","Escitalopram response|Voriconazole response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634017","10",96540331,"10",94780574,634017,622289,"rs140278421","NC_000010.11:94780573:G:C"
"CYP2C19*4A/*35","CYP2C19","","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634019","10",96535124,"10",94775367,634019,622287,"rs12769205","NC_000010.11:94775366:A:G"
"NM_000260.4(MYO7A):c.635G>A (p.Arg212His)","MYO7A","R212H, R201H","Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|not provided|Usher syndrome, type 1B|Retinal dystrophy","Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011850","11",76867950,"11",77156904,11850,26889,"rs28934610","NC_000011.10:77156903:G:A"
"NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)","HRAS|LRRC56","Q61K","not provided|Noonan syndrome 3|Lip and oral cavity carcinoma|Spermatocytic seminoma|Breast neoplasm|Thyroid cancer, nonmedullary, 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012601","11",533875,"11",533875,12601,27640,"rs28933406","NC_000011.10:533874:G:T"
"NM_001104.4(ACTN3):c.1729C>T (p.Arg577Ter)","ACTN3","R577*, R620*","ACTININ, ALPHA-3 POLYMORPHISM|ACTN3 deficiency|Sprinting performance","Conflicting interpretations of pathogenicity, Affects(Last reviewed: Mar 1, 2008)","no assertion criteria provided","VCV000018312","11",66328095,"11",66560624,18312,33351,"rs1815739","NC_000011.10:66560623:C:T"
"NM_000039.2(APOA1):c.589C>T (p.Arg197Cys)","APOA1","R197C, R88C","APOLIPOPROTEIN A-I (MILANO)","Pathogenic(Last reviewed: Nov 5, 2003)","no assertion criteria provided","VCV000017909","11",116706739,"11",116836023,17909,32948,"rs28931573","NC_000011.10:116836022:G:A"
"NM_000218.3(KCNQ1):c.1552C>T (p.Arg518Ter)","KCNQ1","R518*, R391*","not provided|Conduction disorder of the heart|Long QT syndrome|Arrhythmia|KCNQ1-Related Disorders|Cardiovascular phenotype|Congenital long QT syndrome|not specified|Atrial fibrillation, familial, 3|Short QT syndrome 2|Long QT syndrome 1, recessive|Long QT syndrome 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)","criteria provided, conflicting interpretations","VCV000003131","11",2790111,"11",2768881,3131,18170,"rs17215500","NC_000011.10:2768880:C:T"
"NM_181798.1(KCNQ1):c.1366C>T (p.Arg456Cys)","KCNQ1","R583C, R456C","not provided|Congenital long QT syndrome|Short QT syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1","Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)","criteria provided, multiple submitters, no conflicts","VCV000003142","11",2799220,"11",2777990,3142,18181,"rs17221854","NC_000011.10:2777989:C:T"
"NM_001876.4(CPT1A):c.2126G>A (p.Gly709Glu)","CPT1A","G709E","Carnitine palmitoyltransferase 1A deficiency","Pathogenic(Last reviewed: Mar 7, 2013)","no assertion criteria provided","VCV000009069","11",68527709,"11",68760241,9069,24108,"rs28936374","NC_000011.10:68760240:C:T"
"NM_005343.4(HRAS):c.181C>G (p.Gln61Glu)","HRAS|LRRC56","Q61E","Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Hepatocellular carcinoma|Squamous cell lung carcinoma|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Malignant melanoma of skin|Adenocarcinoma of stomach|Acute myeloid leukemia|Pancreatic adenocarcinoma|Multiple myeloma","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376444","11",533875,"11",533875,376444,363323,"rs28933406","NC_000011.10:533874:G:C"
"NM_000256.3(MYBPC3):c.208G>T (p.Glu70Ter)","MYBPC3","E70*","not provided","Likely pathogenic(Last reviewed: Nov 5, 2015)","criteria provided, single submitter","VCV000429923","11",47372874,"11",47351323,429923,421860,"rs11570045","NC_000011.10:47351322:C:A"
"NM_007103.4(NDUFV1):c.1312C>A (p.Leu438Met)","NDUFV1","L438M, L429M","Mitochondrial complex 1 deficiency, nuclear type 4","Likely pathogenic(Last reviewed: Sep 26, 2019)","no assertion criteria provided","VCV000800963","11",67379846,"11",67612375,800963,788853,"rs1127511","NC_000011.10:67612374:C:A"
"NM_181798.1(KCNQ1):c.121G>A (p.Gly41Arg)","KCNQ1","G168R, G41R","Long QT syndrome|Long QT syndrome 1|Arrhythmia|Cardiovascular phenotype|not provided|Congenital long QT syndrome","Pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000053052","11",2591882,"11",2570652,53052,67720,"rs179489","NC_000011.10:2570651:G:A"
"NM_181798.1(KCNQ1):c.1171C>G (p.Arg391Gly)","KCNQ1","R518G, R391G","Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome","Likely pathogenic(Last reviewed: May 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000052991","11",2790111,"11",2768881,52991,67659,"rs17215500","NC_000011.10:2768880:C:G"
"NM_181798.1(KCNQ1):c.121G>C (p.Gly41Arg)","KCNQ1","G168R, G41R","Cardiovascular phenotype|not provided|Congenital long QT syndrome|Long QT syndrome","Pathogenic(Last reviewed: Aug 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000053053","11",2591882,"11",2570652,53053,67721,"rs179489","NC_000011.10:2570651:G:C"
"NM_000277.3(PAH):c.1169A>G (p.Glu390Gly)","PAH","E390G","Phenylketonuria|not provided|Hyperphenylalaninemia, non-pku","Pathogenic(Last reviewed: Oct 1, 2018)","reviewed by expert panel","VCV000000625","12",103237454,"12",102843676,625,15664,"rs5030856","NC_000012.12:102843675:T:C"
"NM_000277.3(PAH):c.727C>T (p.Arg243Ter)","PAH","R243*","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 7, 2018)","reviewed by expert panel","VCV000000588","12",103246708,"12",102852930,588,15627,"rs5030846","NC_000012.12:102852929:G:A"
"NM_000277.3(PAH):c.842C>T (p.Pro281Leu)","PAH","P281L","not provided|Inborn genetic diseases|Phenylketonuria","Likely pathogenic(Last reviewed: Aug 27, 2018)","reviewed by expert panel","VCV000000589","12",103246593,"12",102852815,589,15628,"rs5030851","NC_000012.12:102852814:G:A"
"NM_000277.3(PAH):c.842+1G>A","PAH","","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000599","12",103246592,"12",102852814,599,15638,"rs5030852","NC_000012.12:102852813:C:T"
"NM_000552.4(VWF):c.4751A>G (p.Tyr1584Cys)","VWF","Y1584C","not provided|not specified|von Willebrand disorder|von Willebrand disease, type 1, susceptibility to|Inborn genetic diseases|none provided|von Willebrand disease type 2","Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2021)","criteria provided, conflicting interpretations","VCV000000310","12",6127833,"12",6018667,310,15349,"rs1800386","NC_000012.12:6018666:T:C"
"NM_000785.4(CYP27B1):c.320G>A (p.Arg107His)","CYP27B1","R107H","Vitamin D-dependent rickets type 1A|Vitamin D-dependent rickets, type 1","Likely pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000001658","12",58159856,"12",57766073,1658,16697,"rs28934604","NC_000012.12:57766072:C:T"
"NM_000785.4(CYP27B1):c.374G>A (p.Gly125Glu)","CYP27B1","G125E","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001659","12",58159802,"12",57766019,1659,16698,"rs28934605","NC_000012.12:57766018:C:T"
"NM_000020.2(ACVRL1):c.632G>A (p.Gly211Asp)","ACVRL1","G211D","Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008253","12",52308229,"12",51914445,8253,23292,"rs28936687","NC_000012.12:51914444:G:A"
"NM_000020.3(ACVRL1):c.1031G>A (p.Cys344Tyr)","ACVRL1","C344Y","Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008254","12",52309267,"12",51915483,8254,23293,"rs28936688","NC_000012.12:51915482:G:A"
"NM_000431.4(MVK):c.58C>A (p.His20Asn)","MVK","H20N","Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria","Pathogenic(Last reviewed: Jul 1, 2019)","criteria provided, single submitter","VCV000649235","12",110012685,"12",109574880,649235,640599,"rs11544299","NC_000012.12:109574879:C:A"
"NM_000020.2(ACVRL1):c.1031G>T (p.Cys344Phe)","ACVRL1","C344F","Telangiectasia, hereditary hemorrhagic, type 2","Likely pathogenic(Last reviewed: Oct 16, 2018)","criteria provided, single submitter","VCV000658228","12",52309267,"12",51915483,658228,641250,"rs28936688","NC_000012.12:51915482:G:T"
"NM_000277.3(PAH):c.691T>C (p.Ser231Pro)","PAH","S231P","Phenylketonuria|not provided","Pathogenic(Last reviewed: Apr 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000102786","12",103248929,"12",102855151,102786,108522,"rs5030845","NC_000012.12:102855150:A:G"
"NM_000277.3(PAH):c.842+1G>T","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Apr 9, 2019)","reviewed by expert panel","VCV000102869","12",103246592,"12",102852814,102869,108605,"rs5030852","NC_000012.12:102852813:C:A"
"NM_000277.3(PAH):c.735G>A (p.Val245=)","PAH","","not specified|not provided|Phenylketonuria","Benign(Last reviewed: Apr 24, 2018)","reviewed by expert panel","VCV000092748","12",103246700,"12",102852922,92748,98655,"rs1042503","NC_000012.12:102852921:C:T"
"NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)","SERPINA1","L65P","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI M(PROCIDA)|not provided|Alpha-1-antitrypsin deficiency","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017971","14",94849381,"14",94383044,17971,33010,"rs28931569","NC_000014.9:94383043:A:G"
"NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr)","PSEN1","C410Y, C406Y","Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3","Pathogenic(Last reviewed: Nov 16, 2017)","criteria provided, single submitter","VCV000018127","14",73683933,"14",73217225,18127,33166,"rs661","NC_000014.9:73217224:G:A"
"NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)","SERPINA1","E366K","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|FRAXE|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Inborn genetic diseases|not provided","Pathogenic, risk factor(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017967","14",94844947,"14",94378610,17967,33006,"rs28929474","NC_000014.9:94378609:C:T"
"NM_000137.3(FAH):c.1021C>T (p.Arg341Trp)","FAH","R341W","not provided|Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I","Benign/Likely benign, other(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011868","15",80472526,"15",80180184,11868,26907,"rs11555096","NC_000015.10:80180183:C:T"
"NM_207581.4(DUOXA2):c.738C>G (p.Tyr246Ter)","DUOXA2","Y246*","Thyroglobulin synthesis defect","Pathogenic(Last reviewed: Feb 1, 2008)","no assertion criteria provided","VCV000000444","15",45409472,"15",45117274,444,15483,"rs4774518","NC_000015.10:45117273:C:G"
"NM_000138.4(FBN1):c.2986T>C (p.Cys996Arg)","FBN1","C996R","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Likely pathogenic(Last reviewed: Aug 24, 2017)","criteria provided, single submitter","VCV000527151","15",48782144,"15",48489947,527151,529346,"rs140592","NC_000015.10:48489946:A:G"
"NM_000138.4(FBN1):c.496T>A (p.Cys166Ser)","FBN1","C166S","Cardiovascular phenotype|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000519737","15",48888522,"15",48596325,519737,510639,"rs363852","NC_000015.10:48596324:A:T"
"NM_000138.5(FBN1):c.496T>C (p.Cys166Arg)","FBN1","C166R","Marfan syndrome","Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000803098","15",48888522,"15",48596325,803098,791475,"rs363852","NC_000015.10:48596324:A:G"
"NM_014249.4(NR2E3):c.119-2A>C","NR2E3","","Cone-rod dystrophy|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Goldmann-Favre syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome|Retinitis pigmentosa|NR2E3-Related Disorders|Retinal dystrophy|not provided|not specified|Horizontal nystagmus|Visual impairment|Retinal dystrophy|Abnormality of color vision","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000191059","15",72103821,"15",71811481,191059,188865,"rs2723341","NC_000015.10:71811480:A:C"
"NM_000196.4(HSD11B2):c.637C>T (p.Arg213Cys)","HSD11B2","R213C","Apparent mineralocorticoid excess","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000012094","16",67470018,"16",67436115,12094,27133,"rs28934591","NC_000016.10:67436114:C:T"
"NM_001039.4(SCNN1G):c.547G>A (p.Gly183Ser)","SCNN1G","G183S","Liddle syndrome 2|not provided|not specified|Autosomal recessive pseudohypoaldosteronism type 1|Bronchiectasis with or without elevated sweat chloride 3","Benign/Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008828","16",23200921,"16",23189600,8828,23867,"rs5736","NC_000016.10:23189599:G:A"
"NM_004380.3(CREBBP):c.3524A>G (p.Tyr1175Cys)","CREBBP","Y1175C, Y1137C","Rubinstein-Taybi syndrome 1","Likely pathogenic(Last reviewed: Nov 5, 2019)","criteria provided, single submitter","VCV000009432","16",3807895,"16",3757894,9432,24471,"rs28937315","NC_000016.10:3757893:T:C"
"NM_000558.5(HBA1):c.207C>A (p.Asn69Lys)","HBA1|LOC106804613","N69K","alpha Thalassemia","Pathogenic(Last reviewed: Dec 29, 2016)","no assertion criteria provided","VCV000375748","16",227039,"16",177040,375748,362634,"rs1060339","NC_000016.10:177039:C:A"
"NM_000558.5(HBA1):c.207C>G (p.Asn69Lys)","HBA1|LOC106804613","N69K","none provided|not provided","Likely benign(Last reviewed: Jul 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000439095","16",227039,"16",177040,439095,432867,"rs1060339","NC_000016.10:177039:C:G"
"NM_004608.3(TBX6):c.-49+34G>T","TBX6","","","no interpretation for the single variant","no interpretation for the single variant","VCV000427809","16",30103160,"16",30091839,427809,185945,"rs3809627","NC_000016.10:30091838:C:A"
"NM_001009944.3(PKD1):c.2180T>A (p.Leu727Gln)","PKD1","L727Q","not provided","Uncertain significance(Last reviewed: Feb 1, 2018)","criteria provided, single submitter","VCV000586255","16",2164844,"16",2114843,586255,577527,"rs1616940","NC_000016.10:2114842:A:T"
"NM_001009944.3(PKD1):c.2180T>C (p.Leu727Pro)","PKD1","L727P","Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease 3","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000562302","16",2164844,"16",2114843,562302,553486,"rs1616940","NC_000016.10:2114842:A:G"
"NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)","KRT16","L128Q","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014609","17",39768558,"17",41612306,14609,29648,"rs28928895","NC_000017.11:41612305:A:T"
"NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)","KRT17","L95P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 14, 2015)","criteria provided, single submitter","VCV000014596","17",39780478,"17",41624226,14596,29635,"rs28928899","NC_000017.11:41624225:A:G"
"NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)","KRT17","L95Q","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014595","17",39780478,"17",41624226,14595,29634,"rs28928899","NC_000017.11:41624225:A:T"
"NM_000546.6(TP53):c.747G>T","TP53","R249S, R117S, R210S, R90S","Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Squamous cell carcinoma of the head and neck|Hepatocellular carcinoma|Cancer of cervix|Li-Fraumeni syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2018)","criteria provided, conflicting interpretations","VCV000012352","17",7577534,"17",7674216,12352,27391,"rs28934571","NC_000017.11:7674215:C:A"
"NM_001614.5(ACTG1):c.404C>T (p.Ala135Val)","ACTG1","A135V","not provided|Baraitser-Winter Syndrome 2","Pathogenic(Last reviewed: Feb 1, 2017)","criteria provided, single submitter","VCV000029587","17",79478612,"17",81511586,29587,38541,"rs11549190","NC_000017.11:81511585:G:A"
"NM_000346.4(SOX9):c.507C>T (p.His169=)","SOX9","","not specified|Camptomelic dysplasia|none provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021164","17",70118935,"17",72122794,21164,34016,"rs2229989","NC_000017.11:72122793:C:T"
"NM_000342.4(SLC4A1):c.2561C>T (p.Pro854Leu)","SLC4A1","P854L","Spherocytosis type 4|not provided|not specified|Autosomal dominant distal renal tubular acidosis|DIEGO BLOOD GROUP ANTIGEN|Hemolytic anemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000017768","17",42328621,"17",44251253,17768,32807,"rs2285644","NC_000017.11:44251252:G:A"
"NM_018127.7(ELAC2):c.650C>T (p.Ser217Leu)","ELAC2","S217L","not specified|Combined oxidative phosphorylation deficiency 17|Prostate cancer, hereditary, 2|not provided","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005055","17",12915009,"17",13011692,5055,20094,"rs4792311","NC_000017.11:13011691:G:A"
"NM_000152.3(GAA):c.2065G>A (p.Glu689Lys)","GAA","E689K","not specified|not provided|Glycogen storage disease, type II|Acid alpha-glucosidase, allele 4","Benign, other(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004030","17",78087041,"17",80113242,4030,19069,"rs1800309","NC_000017.11:80113241:G:A"
"NM_000049.4(ASPA):c.693C>A (p.Tyr231Ter)","ASPA|SPATA22","Y231*","Canavan Disease, Familial Form|not provided|Spongy degeneration of central nervous system","Pathogenic(Last reviewed: Dec 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000002609","17",3397702,"17",3494408,2609,17648,"rs12948217","NC_000017.11:3494407:C:A"
"NM_000546.5(TP53):c.329G>T (p.Arg110Leu)","TP53","R110L, R71L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)","criteria provided, multiple submitters, no conflicts","VCV000406597","17",7579358,"17",7676040,406597,402569,"rs11540654","NC_000017.11:7676039:C:A"
"NM_000546.5(TP53):c.747G>C (p.Arg249Ser)","TP53","R210S, R249S, R117S, R90S","Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Nov 9, 2019)","criteria provided, single submitter","VCV000406598","17",7577534,"17",7674216,406598,403018,"rs28934571","NC_000017.11:7674215:C:G"
"NM_000546.5(TP53):c.1015G>T (p.Glu339Ter)","TP53","E207*, E300*, E339*, E180*","Li-Fraumeni syndrome|Li-Fraumeni syndrome 1","Pathogenic(Last reviewed: Feb 16, 2018)","criteria provided, single submitter","VCV000438708","17",7574012,"17",7670694,438708,432338,"rs17882252","NC_000017.11:7670693:C:A"
"NM_000546.6(TP53):c.329G>A (p.Arg110His)","TP53","R110H, R71H","Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|not specified","Likely benign(Last reviewed: Aug 11, 2020)","reviewed by expert panel","VCV000127808","17",7579358,"17",7676040,127808,133265,"rs11540654","NC_000017.11:7676039:C:T"
"NM_000546.5(TP53):c.1015G>C (p.Glu339Gln)","TP53","E207Q, E300Q, E339Q, E180Q","not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Likely benign(Last reviewed: Sep 1, 2020)","reviewed by expert panel","VCV000141893","17",7574012,"17",7670694,141893,151607,"rs17882252","NC_000017.11:7670693:C:G"
"NM_000546.5(TP53):c.1015G>A (p.Glu339Lys)","TP53","E207K, E300K, E339K, E180K","Li-Fraumeni syndrome|Hereditary breast and ovarian cancer syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000142846","17",7574012,"17",7670694,142846,152560,"rs17882252","NC_000017.11:7670693:C:T"
"NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)","KRT16","L128P","not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, single submitter","VCV000265486","17",39768558,"17",41612306,265486,260164,"rs28928895","NC_000017.11:41612305:A:G"
"NM_000346.4(SOX9):c.507C>G (p.His169Gln)","SOX9","H169Q","not provided|Camptomelic dysplasia|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000235914","17",70118935,"17",72122794,235914,237540,"rs2229989","NC_000017.11:72122793:C:G"
"NM_000049.3(ASPA):c.693C>T (p.Tyr231=)","ASPA|SPATA22","","Spongy degeneration of central nervous system|not specified","Benign/Likely benign(Last reviewed: Jul 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000197621","17",3397702,"17",3494408,197621,194782,"rs12948217","NC_000017.11:3494407:C:T"
"NM_000546.5(TP53):c.329G>C (p.Arg110Pro)","TP53","R110P, R71P","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Sep 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233627","17",7579358,"17",7676040,233627,236497,"rs11540654","NC_000017.11:7676039:C:G"
"NM_000371.3(TTR):c.116C>A (p.Ala39Asp)","TTR","A39D","Amyloidogenic transthyretin amyloidosis","Pathogenic(Last reviewed: Aug 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000565560","18",29172905,"18",31592942,565560,570116,"rs11541795","NC_000018.10:31592941:C:A"
"NM_000041.4(APOE):c.487C>T (p.Arg163Cys)","APOE","R163C, R189C","not provided|Familial type 3 hyperlipoproteinemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000017851","19",45412040,"19",44908783,17851,32890,"rs769455","NC_000019.10:44908782:C:T"
"NM_000041.4(APOE):c.455G>A (p.Arg152Gln)","APOE","R152Q, R178Q","APOE2 VARIANT","Pathogenic(Last reviewed: Feb 21, 2017)","no assertion criteria provided","VCV000017874","19",45412008,"19",44908751,17874,32913,"rs28931578","NC_000019.10:44908750:G:A"
"NM_000041.4(APOE):c.940A>C (p.Ser314Arg)","APOE","S314R, S340R","APOE4(+)","Pathogenic(Last reviewed: May 1, 1993)","no assertion criteria provided","VCV000017876","19",45412493,"19",44909236,17876,32915,"rs28931579","NC_000019.10:44909235:A:C"
"NM_001013257.2(BCAM):c.711C>A (p.Cys237Ter)","BCAM","C237*","BLOOD GROUP--LUTHERAN NULL","Pathogenic(Last reviewed: Mar 1, 2007)","no assertion criteria provided","VCV000000442","19",45316804,"19",44813547,442,15481,"rs3810141","NC_000019.10:44813546:C:A"
"NM_000041.4(APOE):c.349G>A (p.Ala117Thr)","APOE","A117T, A143T","","no interpretation for the single variant","no interpretation for the single variant","VCV000478851","19",45411902,"19",44908645,478851,32912,"rs28931577","NC_000019.10:44908644:G:A"
"NM_001037.5(SCN1B):c.254G>A (p.Arg85His)","SCN1B","R85H, R52H","Atrial fibrillation, familial, 13|not provided|Epileptic encephalopathy, early infantile, 52|Generalized epilepsy with febrile seizures plus, type 1|Atrial fibrillation, familial, 13|Brugada syndrome 5|Brugada syndrome 5","Pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000060767","19",35524449,"19",35033545,60767,75309,"rs16969925","NC_000019.10:35033544:G:A"
"NM_000527.5(LDLR):c.2053C>A (p.Pro685Thr)","LDLR","P685T, P644T, P517T","Familial hypercholesterolemia 1","Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, single submitter","VCV000252193","19",11231111,"19",11120435,252193,246488,"rs2569548","NC_000019.10:11120434:C:A"
"NM_000527.5(LDLR):c.2053C>T (p.Pro685Ser)","LDLR","P685S, P644S, P517S","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, multiple submitters, no conflicts","VCV000252194","19",11231111,"19",11120435,252194,246489,"rs2569548","NC_000019.10:11120434:C:T"
"NM_000523.4(HOXD13):c.916C>T (p.Arg306Trp)","HOXD13","R306W","Synpolydactyly 1","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014872","2",176959342,"2",176094614,14872,29911,"rs28933082","NC_000002.12:176094613:C:T"
"NM_006891.4(CRYGD):c.70C>A (p.Pro24Thr)","CRYGD|LOC100507443","P24T","Congenital cataract|Cataract 4|Aculeiform cataract","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000016940","2",208989018,"2",208124294,16940,31979,"rs28931605","NC_000002.12:208124293:G:T"
"NM_006891.4(CRYGD):c.70C>T (p.Pro24Ser)","CRYGD|LOC100507443","P24S","Cataract 4","Pathogenic(Last reviewed: Sep 1, 2007)","no assertion criteria provided","VCV000016942","2",208989018,"2",208124294,16942,31981,"rs28931605","NC_000002.12:208124293:G:A"
"NM_022437.3(ABCG8):c.55G>C (p.Asp19His)","ABCG5|ABCG8","D19H","Sitosterolemia 1|not specified|Sitosterolemia|Gallbladder disease 4","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004975","2",44066247,"2",43839108,4975,20014,"rs11887534","NC_000002.12:43839107:G:C"
"NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly)","BCS1L","S78G","Mitochondrial complex III deficiency, nuclear type 1|Leigh syndrome|Pili torti-deafness syndrome|GRACILE syndrome|not provided|GRACILE syndrome|Mitochondrial complex III deficiency, nuclear type 1","Pathogenic(Last reviewed: Jan 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006167","2",219525942,"2",218661219,6167,21206,"rs28937590","NC_000002.12:218661218:A:G"
"NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)","ALK","D1529E, D461E","Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma|not specified|Neuroblastoma 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133476","2",29416366,"2",29193500,133476,137215,"rs1881421","NC_000002.12:29193499:G:C"
"NM_000523.4(HOXD13):c.916C>G (p.Arg306Gly)","HOXD13","R306G","Synpolydactyly 1","Pathogenic(Last reviewed: Aug 12, 2016)","no assertion criteria provided","VCV000225656","2",176959342,"2",176094614,225656,227492,"rs28933082","NC_000002.12:176094613:C:G"
"NM_000311.5(PRNP):c.598G>A (p.Glu200Lys)","PRNP","E200K","Fatal familial insomnia|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|not provided","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013398","20",4680464,"20",4699818,13398,28437,"rs28933385","NC_000020.11:4699817:G:A"
"NM_001250.6(CD40):c.247T>C (p.Cys83Arg)","CD40","C83R","Hyper-IgM syndrome type 3","Pathogenic(Last reviewed: Dec 23, 2010)","no assertion criteria provided","VCV000017749","20",44750988,"20",46122349,17749,32788,"rs28931586","NC_000020.11:46122348:T:C"
"NM_018419.3(SOX18):c.310G>C (p.Ala104Pro)","TCEA2|SOX18","A104P","Hypotrichosis-lymphedema-telangiectasia syndrome","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000008000","20",62680560,"20",64049207,8000,23039,"rs28936692","NC_000020.11:64049206:C:G"
"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","KCNE1","D85N","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Congenital long QT syndrome|Cardiomyopathy|Long QT syndrome 2/5|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Long QT syndrome 5, acquired, susceptibility to|not specified","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013479","21",35821680,"21",34449382,13479,28518,"rs1805128","NC_000021.9:34449381:C:T"
"NM_000100.4(CSTB):c.43G>T (p.Glu15Ter)","CSTB","E15*","not provided","Likely pathogenic(Last reviewed: Aug 1, 2019)","criteria provided, single submitter","VCV000809294","21",45196108,"21",43776227,809294,798031,"rs11553836","NC_000021.9:43776226:C:A"
"NM_000487.6(ARSA):c.*96A>G","ARSA","","not provided|Metachromatic leukodystrophy|Arylsulfatase A pseudodeficiency|not specified","Benign, other(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000003049","22",51063477,"22",50625049,3049,18088,"rs6151429","NC_000022.11:50625048:T:C"
"NM_213720.3(CHCHD10):c.312C>T (p.Tyr104=)","CHCHD10","","Spinal muscular atrophy, jokela type|not specified|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379953","22",24108412,"22",23766225,379953,378642,"rs9153","NC_000022.11:23766224:G:A"
"NM_000631.5(NCF4):c.118-1G>A","NCF4-AS1|NCF4","","not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III","Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000425281","22",37260960,"22",36864918,425281,413615,"rs28445840","NC_000022.11:36864917:G:A"
"NM_213720.3(CHCHD10):c.312C>G (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000565755","22",24108412,"22",23766225,565755,573956,"rs9153","NC_000022.11:23766224:G:C"
"NM_213720.3(CHCHD10):c.312C>A (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Uncertain significance(Last reviewed: Nov 28, 2019)","criteria provided, single submitter","VCV000569761","22",24108412,"22",23766225,569761,571718,"rs9153","NC_000022.11:23766224:G:T"
"NM_007194.4(CHEK2):c.1039G>A (p.Asp347Asn)","CHEK2","D347N, D280N, D390N, D126N","Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000182432","22",29092945,"22",28696957,182432,181104,"rs28909980","NC_000022.11:28696956:C:T"
"NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)","SLC25A20","Q238R","Carnitine acylcarnitine translocase deficiency|not provided","Pathogenic(Last reviewed: Dec 17, 2013)","criteria provided, multiple submitters, no conflicts","VCV000012138","3",48896530,"3",48859097,12138,27177,"rs28934589","NC_000003.12:48859096:T:C"
"NM_000539.3(RHO):c.173C>G (p.Thr58Arg)","RHO","T58R","not provided|Retinal dystrophy|Retinitis pigmentosa 4","Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013016","3",129247749,"3",129528906,13016,28055,"rs28933394","NC_000003.12:129528905:C:G"
"NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)","TGFBR2","L308P, L333P","Loeys-Dietz syndrome 2","Pathogenic(Last reviewed: Apr 1, 2010)","no assertion criteria provided","VCV000012505","3",30713598,"3",30672106,12505,27544,"rs28934568","NC_000003.12:30672105:T:C"
"NM_001354689.3(RAF1):c.775T>A (p.Ser259Thr)","RAF1","S259T, S145T, S178T, S226T","Noonan syndrome|Rasopathy|not provided","Pathogenic(Last reviewed: Apr 3, 2017)","reviewed by expert panel","VCV000040601","3",12645694,"3",12604195,40601,49071,"rs3730271","NC_000003.12:12604194:A:T"
"NM_000551.4(VHL):c.463+2T>G","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Nov 30, 2009)","no assertion criteria provided","VCV000043602","3",10188322,"3",10146638,43602,52771,"rs5030814","NC_000003.12:10146637:T:G"
"NM_003865.3(HESX1):c.478C>T (p.Arg160Cys)","HESX1","R160C","Septo-optic dysplasia sequence","Pathogenic(Last reviewed: Jun 1, 1998)","no assertion criteria provided","VCV000007691","3",57232305,"3",57198277,7691,22730,"rs28936702","NC_000003.12:57198276:G:A"
"NM_001330615.1(PPARG):c.735+10750G>A","PPARG","R288H, R77H, R316H","Carcinoma of colon","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000008135","3",12458330,"3",12416831,8135,23174,"rs28936407","NC_000003.12:12416830:G:A"
"NM_001354689.3(RAF1):c.775T>G (p.Ser259Ala)","RAF1","S259A, S226A, S178A, S145A","not provided|Rasopathy|not specified","Pathogenic(Last reviewed: Jun 25, 2020)","reviewed by expert panel","VCV000504514","3",12645694,"3",12604195,504514,496336,"rs3730271","NC_000003.12:12604194:A:C"
"NM_000551.3(VHL):c.533T>C (p.Leu178Pro)","VHL|LOC107303340","L178P, L137P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428795","3",10191540,"3",10149856,428795,420453,"rs5030822","NC_000003.12:10149855:T:C"
"NM_000551.3(VHL):c.533T>A (p.Leu178Gln)","VHL|LOC107303340","L178Q, L137Q","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625260","3",10191540,"3",10149856,625260,613591,"rs5030822","NC_000003.12:10149855:T:A"
"NM_000551.3(VHL):c.533T>G (p.Leu178Arg)","VHL|LOC107303340","L178R, L137R","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625261","3",10191540,"3",10149856,625261,613592,"rs5030822","NC_000003.12:10149855:T:G"
"NM_000551.3(VHL):c.463+2T>C","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 5, 2018)","criteria provided, single submitter","VCV000569414","3",10188322,"3",10146638,569414,561087,"rs5030814","NC_000003.12:10146637:T:C"
"NM_000551.3(VHL):c.233A>G (p.Asn78Ser)","VHL","N78S","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Pathogenic(Last reviewed: Oct 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093326","3",10183764,"3",10142080,93326,99233,"rs5030804","NC_000003.12:10142079:A:G"
"NM_000313.3(PROS1):c.233C>T (p.Thr78Met)","PROS1","T78M, T110M","Protein S deficiency disease|Deep venous thrombosis|Thrombophilia due to protein S deficiency, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2020)","criteria provided, conflicting interpretations","VCV000215991","3",93646095,"3",93927251,215991,212340,"rs6122","NC_000003.12:93927250:G:A"
"NM_001354689.3(RAF1):c.775T>C (p.Ser259Pro)","RAF1","S259P, S145P, S178P, S226P","Rasopathy|Noonan syndrome","Likely pathogenic(Last reviewed: Jan 29, 2018)","criteria provided, multiple submitters, no conflicts","VCV000228288","3",12645694,"3",12604195,228288,229012,"rs3730271","NC_000003.12:12604194:A:G"
"NM_000551.3(VHL):c.233A>C (p.Asn78Thr)","VHL","N78T","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2019)","criteria provided, conflicting interpretations","VCV000223168","3",10183764,"3",10142080,223168,224899,"rs5030804","NC_000003.12:10142079:A:C"
"NM_000551.3(VHL):c.337C>T (p.Arg113Ter)","VHL","R113*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 26, 2016)","criteria provided, single submitter","VCV000220414","3",10183868,"3",10142184,220414,221350,"rs5030810","NC_000003.12:10142183:C:T"
"NM_000551.3(VHL):c.233A>T (p.Asn78Ile)","VHL","N78I","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Nov 27, 2018)","criteria provided, single submitter","VCV000223169","3",10183764,"3",10142080,223169,224900,"rs5030804","NC_000003.12:10142079:A:T"
"NM_003102.3(SOD3):c.691C>G (p.Arg231Gly)","SOD3","R213G, R231G","Superoxide dismutase, elevated extracellular","Pathogenic(Last reviewed: Jan 6, 2004)","no assertion criteria provided","VCV000012777","4",24801834,"4",24800212,12777,27816,"rs1799895","NC_000004.12:24800211:C:G"
"NM_000142.5(FGFR3):c.1950G>T (p.Lys650Asn)","FGFR3","K650N, K652N, K538N, K651N","Hypochondroplasia","Pathogenic(Last reviewed: Sep 26, 2013)","no assertion criteria provided","VCV000016346","4",1807891,"4",1806164,16346,31385,"rs28928868","NC_000004.12:1806163:G:T"
"NM_000142.5(FGFR3):c.1950G>C (p.Lys650Asn)","FGFR3","K650N, K652N, K651N, K538N","Craniosynostosis syndrome|not provided|Hypochondroplasia","Pathogenic(Last reviewed: Sep 27, 2017)","criteria provided, multiple submitters, no conflicts","VCV000016347","4",1807891,"4",1806164,16347,31386,"rs28928868","NC_000004.12:1806163:G:C"
"NM_003060.4(SLC22A5):c.51C>G (p.Phe17Leu)","SLC22A5","F17L","Renal carnitine transport defect|not provided","Pathogenic(Last reviewed: Oct 12, 2020)","criteria provided, multiple submitters, no conflicts","VCV000025350","5",131705715,"5",132370023,25350,36684,"rs11568520","NC_000005.10:132370022:C:G"
"NM_007255.3(B4GALT7):c.808C>T (p.Arg270Cys)","B4GALT7","R270C","Lethal skeletal dysplasia|not provided|Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|Ehlers-Danlos syndrome, spondylodysplastic type, 1","Pathogenic(Last reviewed: Aug 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005613","5",177035995,"5",177608994,5613,20652,"rs28937869","NC_000005.10:177608993:C:T"
"NM_004168.4(SDHA):c.1A>C (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1","Pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, single submitter","VCV000008744","5",218471,"5",218356,8744,23783,"rs1061517","NC_000005.10:218355:A:C"
"NM_004168.4(SDHA):c.1A>G (p.Met1Val)","SDHA","M1V","Hereditary cancer-predisposing syndrome|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000239661","5",218471,"5",218356,239661,239796,"rs1061517","NC_000005.10:218355:A:G"
"NM_004168.4(SDHA):c.1A>T (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000371794","5",218471,"5",218356,371794,358789,"rs1061517","NC_000005.10:218355:A:T"
"NM_000129.3(F13A1):c.-19+12=","F13A1","","Factor XIII, A subunit, deficiency of","Pathogenic(Last reviewed: Jul 1, 2011)","no assertion criteria provided","VCV000029695","6",6320808,"6",6320575,29695,38650,"rs2815822","NC_000006.12:6320574:T:T"
"NM_000500.9(CYP21A2):c.40G>T (p.Ala14Ser)","CYP21A2|LOC106780800","A14S","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Uncertain significance","no assertion criteria provided","VCV000998097","6",32006239,"6",32038462,998097,985825,"rs6445","NC_000006.12:32038461:G:T"
"NM_000426.3(LAMA2):c.2750-1G>C","LAMA2","","not provided","Pathogenic(Last reviewed: Feb 12, 2013)","criteria provided, single submitter","VCV000092947","6",129612758,"6",129291613,92947,98854,"rs9492297","NC_000006.12:129291612:G:C"
"NM_000129.3(F13A1):c.-19+12A>C","F13A1","","Factor XIII, A subunit, deficiency of|not specified","Benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000357680","6",6320808,"6",6320575,357680,300863,"rs2815822","NC_000006.12:6320574:T:G"
"NM_172056.2(KCNH2):c.1778T>G (p.Ile593Arg)","KCNH2","I593R, I253R","Congenital long QT syndrome|not provided|Long QT syndrome 2","Pathogenic(Last reviewed: May 24, 2019)","criteria provided, single submitter","VCV000014423","7",150648703,"7",150951615,14423,29462,"rs28928904","NC_000007.14:150951614:A:C"
"NM_172056.2(KCNH2):c.1714G>C (p.Gly572Arg)","KCNH2","G572R, G232R","Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Feb 1, 2000)","no assertion criteria provided","VCV000014429","7",150648767,"7",150951679,14429,29468,"rs9333649","NC_000007.14:150951678:C:G"
"NM_005228.5(EGFR):c.2155G>C (p.Gly719Arg)","EGFR","G719R, G666R, G452R, G674R","Non-small cell lung cancer|Squamous cell carcinoma of the head and neck","Likely pathogenic, drug response(Last reviewed: Aug 10, 2009)","no assertion criteria provided","VCV000045224","7",55241707,"7",55174014,45224,54391,"rs28929495","NC_000007.14:55174013:G:C"
"NM_005228.5(EGFR):c.2155G>T (p.Gly719Cys)","EGFR","G719C, G452C, G674C, G666C","Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Glioblastoma|Non-small cell lung cancer|Lung adenocarcinoma","Pathogenic/Likely pathogenic, drug response(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000016611","7",55241707,"7",55174014,16611,31650,"rs28929495","NC_000007.14:55174013:G:T"
"NM_005228.5(EGFR):c.2155G>A (p.Gly719Ser)","EGFR","G719S, G452S, G674S, G666S","Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Tyrosine kinase inhibitor response|Neoplasm of the large intestine|Non-small cell lung cancer","drug response(Last reviewed: Apr 20, 2012)","criteria provided, single submitter","VCV000016612","7",55241707,"7",55174014,16612,31651,"rs28929495","NC_000007.14:55174013:G:A"
"NM_172056.2(KCNH2):c.1714G>A (p.Gly572Ser)","KCNH2","G232S, G572S","not provided|Cardiovascular phenotype|Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Nov 8, 2019)","criteria provided, multiple submitters, no conflicts","VCV000067248","7",150648767,"7",150951679,67248,78144,"rs9333649","NC_000007.14:150951678:C:T"
"NM_172056.2(KCNH2):c.1714G>T (p.Gly572Cys)","KCNH2","G232C, G572C","Congenital long QT syndrome","not provided","no assertion provided","VCV000067249","7",150648767,"7",150951679,67249,78145,"rs9333649","NC_000007.14:150951678:C:A"
"NM_172056.2(KCNH2):c.1778T>A (p.Ile593Lys)","KCNH2","I253K, I593K","Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Jul 25, 2017)","criteria provided, single submitter","VCV000067269","7",150648703,"7",150951615,67269,78165,"rs28928904","NC_000007.14:150951614:A:T"
"NM_172056.2(KCNH2):c.1778T>C (p.Ile593Thr)","KCNH2","I253T, I593T","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: Feb 2, 2014)","criteria provided, single submitter","VCV000067270","7",150648703,"7",150951615,67270,78166,"rs28928904","NC_000007.14:150951614:A:G"
"NM_000535.7(PMS2):c.121G>T (p.Glu41Ter)","PMS2","E41*","Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms","Pathogenic(Last reviewed: Jan 31, 2016)","criteria provided, single submitter","VCV000219674","7",6045565,"7",6005934,219674,221737,"rs3209663","NC_000007.14:6005933:C:A"
"NM_002467.6(MYC):c.214C>T (p.Pro72Ser)","MYC","P72S, P71S","Burkitt lymphoma","Pathogenic(Last reviewed: Sep 1, 1993)","no assertion criteria provided","VCV000012574","8",128750677,"8",127738431,12574,27613,"rs28933407","NC_000008.11:127738430:C:T"
"NM_003235.5(TG):c.5986T>A (p.Cys1996Ser)","TG","C1996S","Iodotyrosyl coupling defect","Pathogenic(Last reviewed: Aug 1, 2006)","no assertion criteria provided","VCV000012694","8",133984049,"8",132971804,12694,27733,"rs2076739","NC_000008.11:132971803:T:A"
"NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)","SLURP1","M1L","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004604","8",143823803,"8",142742385,4604,19643,"rs28937889","NC_000008.11:142742384:T:G"
"NM_000498.3(CYP11B2):c.541C>T (p.Arg181Trp)","CYP11B2|LOC106799834","R181W","Corticosterone methyl oxidase type II deficiency|not provided","Uncertain significance(Last reviewed: Oct 25, 2020)","criteria provided, single submitter","VCV000242773","8",143996516,"8",142915100,242773,31915,"rs28931609","NC_000008.11:142915099:G:A"
"NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)","NPR2","W115G","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017785","9",35792748,"9",35792751,17785,32824,"rs28931582","NC_000009.12:35792750:T:G"
"NM_004473.4(FOXE1):c.170G>A (p.Ser57Asn)","FOXE1","S57N","Bamforth-Lazarus syndrome","Pathogenic(Last reviewed: Mar 1, 2011)","no assertion criteria provided","VCV000006987","9",100616366,"9",97854084,6987,22026,"rs28937575","NC_000009.12:97854083:G:A"
"NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro)","ALDOB","A150P","not provided|Hereditary fructosuria","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000464","9",104189856,"9",101427574,464,15503,"rs1800546","NC_000009.12:101427573:C:G"
"NM_000077.4(CDKN2A):c.-34G>A","CDKN2A","","Melanoma-pancreatic cancer syndrome|Hereditary melanoma|not specified","Likely benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379882","9",21974860,"9",21974861,379882,371197,"rs1800586","NC_000009.12:21974860:C:T"
"NM_000077.4(CDKN2A):c.-34G>T","CDKN2A","","Cutaneous malignant melanoma 2|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome|Melanoma-pancreatic cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary melanoma","Pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182414","9",21974860,"9",21974861,182414,180325,"rs1800586","NC_000009.12:21974860:C:A"
"NM_001365068.1(ASTN2):c.2806+26807G>A","TRIM32|ASTN2","R408C","not provided|Bardet-Biedl syndrome|Sarcotubular myopathy|Bardet-Biedl syndrome 11|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)","criteria provided, conflicting interpretations","VCV000100583","9",119461243,"9",116698964,100583,106460,"rs3747835","NC_000009.12:116698963:C:T"
"NM_000077.4(CDKN2A):c.-34G>C","CDKN2A","","Hereditary melanoma|Melanoma-pancreatic cancer syndrome|not specified|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000245907","9",21974860,"9",21974861,245907,244550,"rs1800586","NC_000009.12:21974860:C:G"
"NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)","GLUD2","S445A, S498A","Parkinson disease, late-onset","Pathogenic(Last reviewed: Mar 1, 2010)","no assertion criteria provided","VCV000029936","X",120183030,"X",121049176,29936,38891,"rs9697983","NC_000023.11:121049175:T:G"
"NM_001363.5(DKC1):c.961C>G (p.Leu321Val)","DKC1","L321V","Dyskeratosis congenita, X-linked","Pathogenic(Last reviewed: May 10, 2012)","no assertion criteria provided","VCV000038958","X",153999079,"X",154770804,38958,47561,"rs2728726","NC_000023.11:154770803:C:G"
"NM_006915.3(RP2):c.353G>A (p.Arg118His)","RP2","R118H","Retinitis pigmentosa 2|Retinal dystrophy|not provided","Pathogenic(Last reviewed: Oct 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000010546","X",46713161,"X",46853726,10546,25585,"rs28933687","NC_000023.11:46853725:G:A"
"NM_006915.3(RP2):c.353G>T (p.Arg118Leu)","RP2","R118L","Retinitis pigmentosa 2","Pathogenic(Last reviewed: Aug 1, 2001)","no assertion criteria provided","VCV000010549","X",46713161,"X",46853726,10549,25588,"rs28933687","NC_000023.11:46853725:G:T"
"NM_000132.3(F8):c.1174T>C (p.Ser392Pro)","F8","S392P","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1994)","no assertion criteria provided","VCV000010206","X",154194798,"X",154966523,10206,25245,"rs28933669","NC_000023.11:154966522:A:G"
"NM_000132.3(F8):c.1175C>A (p.Ser392Ter)","F8","S392*","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1993)","no assertion criteria provided","VCV000010204","X",154194797,"X",154966522,10204,25243,"rs28933668","NC_000023.11:154966521:G:T"
"NM_000132.3(F8):c.1175C>T (p.Ser392Leu)","F8","S392L","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1993)","no assertion criteria provided","VCV000010205","X",154194797,"X",154966522,10205,25244,"rs28933668","NC_000023.11:154966521:G:A"
"NM_000047.2(ARSL):c.1732C>T (p.Pro578Ser)","ARSL","P578S, P524S, P603S, P587S","X-linked chondrodysplasia punctata 1","Pathogenic(Last reviewed: Nov 3, 2011)","no assertion criteria provided","VCV000011528","X",2852911,"X",2934870,11528,26567,"rs28935474","NC_000023.11:2934869:G:A"
"NM_001110556.2(FLNA):c.760G>A (p.Glu254Lys)","FLNA","E254K","Oto-palato-digital syndrome, type II|not provided","Pathogenic(Last reviewed: Feb 11, 2015)","criteria provided, single submitter","VCV000011756","X",153595873,"X",154367505,11756,26795,"rs28935470","NC_000023.11:154367504:C:T"
"NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)","AVPR2","R113W","Nephrogenic diabetes insipidus, X-linked","Pathogenic(Last reviewed: May 27, 1993)","no assertion criteria provided","VCV000010840","X",153171297,"X",153905843,10840,25879,"rs28935496","NC_000023.11:153905842:C:T"
"NM_000061.2(BTK):c.370T>C (p.Trp124Arg)","BTK","W124R, W158R","not provided","Likely pathogenic(Last reviewed: Nov 11, 2015)","criteria provided, single submitter","VCV000381633","X",100625007,"X",101370019,381633,378793,"rs7474275","NC_000023.11:101370018:A:G"
